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4FOREWORD
This	report	has	been	produced	to	support	the	work	of	the	Schizophrenia	Commission	during	
its	year-long	inquiry	into	the	care,	treatment	and	outcomes	for	people	with	schizophrenia	and	
psychosis.	This	illness	is	highly	distressing,	with	a	15-20	year	mortality	gap	compared	to	the	
general	population.	The	human	costs	are	immense,	but	so	too	are	the	financial	costs.	For	example,	
the	cost	of	schizophrenia	to	English	society	is	£11.8	billion	per	year.	
Bringing	the	information	together	for	this	report	has	been	challenging.	Although	building	on	
research	that	some	of	us	(Michael,	Paul,	myself)	have	undertaken	over	a	period	of	many	years,	it	
has	been	hugely	influenced	by	the	other	two	authors:	by	Marija’s	MSc	work	on	peer	support	and	
particularly	by	Alison’s	‘summer	job’	at	LSE,	when	she	searched	energetically,	analysed	expertly	
and	summarised	results	clearly	across	a	wide	span	of	topics.
It	will	be	clear	from	the	report	that	there	are	areas	where	we	still	know	little	about	the	costs	of	
delivering	services	and	even	less	about	the	longer-term	economic	impacts.	Nevertheless,	there	is	
robust	evidence	around	some	interventions,	making	a	strong	economic	case	for	change.	We	hope	
that	the	work	of	the	Schizophrenia	Commission	can	drive	forward	some	of	the	changes	required	to	
improve	quality	of	care	and	quality	of	lives.	
We	are	grateful	to	members	of	the	Schizophrenia	Commission	for	their	support,	especially	to	
Liz	Meek	and	Robin	Murray	for	comments,	and	we	are	particularly	grateful	to	Vanessa	Pinfold	
for	her	enthusiasm	throughout	the	process	of	pulling	this	together.	We	would	also	like	to	thank	
Paul	Rowlands	and	Mike	Akroyd	from	Derbyshire	Healthcare	NHS	Foundation	Trust,	and	Sophia	
Winterbourne	(LSE)	for	access	to	very	useful	information.
The	work	for	this	report	was	funded	by	the	Personal	Social	Services	Research	Unit	at	the	LSE.	
The	authors	have	no	conflicts	of	interest	to	declare	except	that	I	am	a	Vice	President	of	the	British	
Association	of	Counselling	and	Psychotherapy.
	
PROFESSOR MARTIN KNAPP
PSSRU,	London	School	of	Economics	and	Political	Science
Institute	of	Psychiatry,	King’s	College	London
5This	report	describes	the	main	costs	associated	with	
schizophrenia	and	assesses	the	economic	case	for	a	
broad	range	of	effective	interventions	that,	if	made	more	
widely	available,	could	lead	to	better	outcomes	and	
potentially	reduce	costs.	
EXECUTIVE SUMMARY
CURRENT COSTS OF 
SCHIZOPHRENIA
Schizophrenia	has	very	significant	economic	
consequences.	Costs	fall	on	many	different	
parts	of	society,	especially	on	individuals	with	
schizophrenia	and	their	families.	Overall,	the	
total	societal	cost	in	England	is	estimated	
at	£11.8	billion	per	year	and	the	cost	to	the	
public	sector	at	£7.2	billion.	This	equates	to	an	
average	annual	cost	to	society	of	£60,000	and	
to	the	public	sector	of	£36,000	per	person	with	
schizophrenia.	
These	costs	arise	in	many	different	ways.	
Some	direct	costs	of	schizophrenia	appear	
both	as	costs	to	society	and	to	the	public	
sector:	examples	are	in-patient	hospital	costs	
and	support	from	community	mental	health	
teams.	Other	costs,	such	as	those	associated	
with	unpaid	care	by	family	or	friends,	are	very	
real	costs	for	society	but	do	not	have	a	direct	
impact	on	public	spending.	Lost	potential	
output	due	to	higher	unemployment	rates	
and	premature	mortality	for	people	with	
schizophrenia	represent	huge	costs	for	society	
and	also	translate	into	indirect	costs	for	the	
public	sector	via	the	loss	of	tax	revenue.	We	
identify	eight	key	cost	drivers	associated	
with	schizophrenia:	inpatient	time;	disrupted	
/	loss	of	employment;	disrupted	education;	
homelessness;	physical	health	problems;	
substance	misuse;	contact	with	the	criminal	
justice	system;	and	the	impact	on	the	family.	
In	our	work	we	found	many	areas	where	the	
availability	and	quality	of	economic	evidence	
were	disappointing,	both	in	terms	of	accurately	
estimating	the	true	costs	associated	with	
schizophrenia	and	in	being	able	to	draw	
firm	conclusions.	We	identified	a	particular	
lack	of	evidence	relating	to	costs	incurred	
through	disrupted	educational	opportunities,	
homelessness	and	contact	with	the	criminal	
justice	system.	
Due	to	the	nature	of	schizophrenia,	many	
related	costs	are	non-retrievable.	Our	work	
focused	on	areas	of	the	current	care	and	
treatment	system	in	England	that	could	
potentially	be	made	more	cost-effective.	
EVALUATING VARIOUS 
INTERVENTIONS 
There	are	a	wide	range	of	interventions	that	are	
relevant	for	the	care	and	treatment	of	people	
with	schizophrenia.	In	this	work	we	have	looked	
at:	early	interventions;	Individual	Placement	
and	Support	schemes;	family	therapy;	
diversion	from	the	criminal	justice	system;	
physical	health;	substance	misuse;	targeting	
homelessness	and	supported	housing;	crisis	
teams;	the	role	of	peer-support	workers;	
advanced	treatment	directives;	and	cognitive	
behaviour	therapy.	
6When	assessing	the	various	interventions,	we	
were	hampered	by	the	lack	of	robust	economic	
evidence	relating	to	some	of	them,	in	particular	
physical	health	interventions,	advanced	
treatment	directives	and	criminal	justice	
interventions.
There	is	nevertheless	strong	evidence	
that	several	interventions	not	currently	in	
widespread	use	could	reduce	the	overall	cost	
of	schizophrenia	while	improving	health	and	
quality	of	life	outcomes	for	people	with	the	
illness	and	for	their	families.	One	intervention	
for	which	there	is	strong	cost-effectiveness	
evidence,	but	which	is	not	available	to	many	
people,	is	Individual	Placement	and	Support,	
which	aims	to	help	people	with	schizophrenia	
find	competitive	employment.	We	also	found	
good	evidence	that	family	therapy,	currently	
offered	to	very	few	people	with	schizophrenia,	
was	cost-effective.	In	other	areas	–	such	as	
physical	health,	substance	misuse,	peer-
support,	advanced	treatment	directives	and	
interventions	to	tackle	homelessness	–	we	
found	some	evidence	of	cost-effectiveness	but	
not	enough	to	draw	firm	conclusions.	
The	evidence	we	identified	came	down	strongly	
in	support	of	early	intervention	services	that,	
although	currently	in	widespread	use,	might	be	
under	threat	in	an	era	of	austerity.	There	is	also	
evidence	that	other	interventions	which	are	
already	in	place,	such	as	crisis	teams,	could	be	
utilised	more	effectively.
In	many	cases,	economic	advantages	might	
take	many	years	to	be	fully	realised.	For	
example,	interventions	to	improve	the	physical	
health	of	people	with	schizophrenia	can	be	
effective	and	cost-effective,	but	with	impacts	
that	show	themselves	over	quite	a	long	period.	
The	full	economic	consequences	of	early	
intervention	services	will	also	not	be	seen	
immediately;	and	the	(so	far	unmeasured)	
consequences	of	disrupted	education	
would	certainly	have	long-term	economic	
consequences.	When	costs	and	benefits	occur	
over	long	time	periods	it	can	be	difficult	to	
obtain	accurate	estimates	of	the	economic	
impacts	of	interventions,	since	the	data	are	
rarely	available.	It	may	also	be	particularly	
difficult	in	the	current	era	of	austerity	to	argue	
successfully	for	interventions	where	savings	
only	become	apparent	over	relatively	long	
timescales.	
Costs	and	savings	relating	to	interventions	
do	not	always	arise	in	the	same	area	of	public	
spending.	One	consequent	challenge	is	likely	to	
be	a	need	for	negotiation	to	agree	joint	courses	
of	action	across	government	departments,	
local	council	budget	areas	or	more	widely.	A	
good	example	would	be	interventions	to	tackle	
homelessness	which	can	originate	in	a	number	
of	different	sectors,	and	have	pay-offs	similarly	
across	a	wide	range	of	budgets.	
It	is	also	the	case	that	many	interventions	
can	cost	more	than	they	save.	Here	decision-
makers	will	need	to	ask	whether	the	improved	
outcomes	that	are	generate	justify	the	costs	
that	will	be	incurred.
CONCLUSIONS
It	was	not	our	intention	with	this	report	to	
recommend	a	particular	‘package’	of	ideal	
interventions,	rather	to	offer	a	summary	of	
evidence	on	costs	and	cost-effectiveness	
as	a	platform	for	discussion.	Our	review	has	
established	that	there	are	areas	of	the	current	
system	for	the	care	and	treatment	of	people	
with	schizophrenia	in	England	that	could	be	
made	more	cost-effective.	There	is	robust	
evidence	around	some	interventions	which	
suggests	a	strong	economic	case	for	change.
7CURRENT COSTS OF 
SCHIZOPHRENIA
1.  Estimates made from uprating cost estimates by Mangalore and Knapp (2007) to 2010/11 prices (using price indices 
specific to each cost area), uprating estimated number of people with schizophrenia in England to the recent 
estimate by NICE of 197,000 (www.nice.org.uk/usingguidance/commissioningguides/schizophrenia) and using an 
18% average indirect tax and an 18% average income tax on all earnings. Figures reported here do not include the 
more intangible costs of the pain and suffering incurred by individuals with schizophrenia and their loved ones.
Schizophrenia	has	very	significant	economic	
consequences;	the	costs	impact	on	many	different	parts	
of	society,	especially	on	individuals	with	schizophrenia	
and	their	families.	Overall,	schizophrenia	is	estimated	to	
cost	English	society	£11.8	billion	per	year	and	the	public	
sector	£7.2	billion.1	This	amounts	to	an	average	annual	
cost	to	society	of	£60,000	and	to	the	public	sector	of	
£36,000	per	person	with	schizophrenia.	
Figure 1: Annual costs of schizophrenia to society and the public sector 
(£,2010/11 prices, per person with schizophrenia)
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8Figure	1	shows	how	these	cost	estimates		
break	down.	Some	direct	costs	of	
schizophrenia,	such	as	in-patient	hospital	
costs	and	support	from	community	mental	
health	teams,	are	common	components	of	
both	the	cost	to	the	public	sector	and	the	cost	
to	society.	Other	costs,	such	as	unpaid	care,	
do	not	cost	the	public	sector	directly	but	are	
still	very	real	costs	for	society.	Lost	potential	
output	due	to	elevated	unemployment	rates	
and	premature	mortality	for	people	with	
schizophrenia	translate	into	huge	costs	for	
society	and	also	translate	into	costs	for	the	
public	sector	via	the	loss	of	tax	revenue.
Evidently,	schizophrenia	is	hugely	expensive	
both	to	the	public	purse	and	society	at	large.	
Due	to	the	nature	of	the	condition	many	of	
these	costs	are	non-retrievable	–	no	treatment	
or	therapy	will	be	able	to	get	every	service	user	
into	full-time	employment	for	example,	and	
expensive	treatments	and	medications	may	
always	be	required.	In	this	report,	however,	
we	contend	that	there	are	areas	of	the	current	
system	for	the	care	and	treatment	of	people	
with	schizophrenia	in	England	that	could	be	
made	more	cost-effective.	The	purpose	of	the	
report	is	to	summarise	the	main	economic	
impacts	of	schizophrenia,	and	then	to	consider	
a	range	of	interventions	(using	that	term	
broadly)	that,	if	made	more	widely	available,	
could	lead	to	better	outcomes	and	lower	costs.	
It	is	not	our	intention	to	recommend	a	particular	
‘package’	of	ideal	interventions,	rather	to	offer	
a	summary	of	evidence	on	costs	and	cost-
effectiveness	as	a	platform	for	discussion.	
There	are	a	number	of	important	elements	in	
the	overall	costs	of	schizophrenia	summarised	
in	Figure	1,	and	it	is	helpful	to	focus	on	some	
of	the	key	cost ‘drivers’.	In	fact,	we	can	
identify	eight	key	cost	drivers	associated	with	
schizophrenia:	areas,	events	or	experiences	
that	account	for	or	help	to	explain	significant	
proportions	of	the	cost	associated	with	
schizophrenia.	By	considering	each	of	
these	drivers	we	can	subsequently	focus	on	
interventions	that	may	have	the	potential	to	
reduce	the	economic	impact	of	these	drivers	
while	maintaining	or	improving	the	health	and	
well-being	of	individuals	with	schizophrenia	and	
their	families.
Most	of	the	evidence	that	we	summarise	in	this	
report	relates	to	people	with	schizophrenia,	
although	sometimes	the	studies	that	we	discuss	
looked	at	a	wider	group	of	people,	such	as	
people	with	the	diagnosis	of	schizophrenia	
and	other	psychotic	illnesses,	or	people	with	
serious	or	severe	mental	illnesses.	We	have	
endeavoured	to	be	clear	about	the	groups	of	
people	covered	as	we	discuss	the	evidence.	
We	recognise	that	the	term	schizophrenia	
and	psychosis	in	clinical	services	are	used	
interchangeably	but	most	research	uses	the	
term	‘schizophrenia’.
INPATIENT TIME
Most	individuals	with	schizophrenia	have	at	
least	one	inpatient	stay,	with	a	high	probability	
of	readmission	(Allardyce	&	Os	2010).	
Inpatient	time	accounts	for	a	very	significant	
proportion	of	the	costs	associated	with	
schizophrenia,	roughly	38%	of	all	health,	social	
care	and	institutional	costs	associated	with	the	
condition,	and	roughly	21%	of	all	public	sector	
costs.2	The	average	cost	of	a	night	in	a	mental	
health	inpatient	bed	in	England	is	£321	(Curtis	
2011).	Hospital	Episode	Statistics	(HESonline	
2011)	show	that	the	median	length	of	admission	
is	38	days,	translating	into	an	estimated	cost	of	
£12,198	per	admission.3	Typically,	compulsory	
(or	formal)	admissions	under	the	Mental	Health	
Act	are	longer	than	this,	and	thus	translate	
into	higher	costs	than	voluntary	admissions.	
Due	to	the	very	high	costs	associated	with	
inpatient	services,	interventions	that	reduce	
the	probability	of	admission	or	reduce	the	
expected	length	of	stay	can	translate	into	very	
significant	cost	savings,	although	this	should	
not	be	at	the	expense	of	poorer	health,	quality	
of	life	or	other	outcomes.	
For	many	people	with	schizophrenia,	an	
inpatient	admission	is	a	necessary	and	perhaps	
important	turning	point	in	the	course	of	their	
illness,	but	in	other	instances	admission	could	
be	avoided	if	more	and	better	interventions	
were	available	outside	the	inpatient	setting.	
Likewise,	in	terms	of	reducing	the	length	of	
admission,	a	recent	Cochrane	review	(although	
the	included	studies	were	dated)	found	no	
evidence	of	adverse	outcomes	from	shorter	
2. Calculated from Mangalore and Knapp (2007).
3. Mean length of stay is 130 days. Data are heavily skewed due to a small proportion of individuals who are admitted to 
long-stay units.
9hospital	stays	and	some	evidence	of	benefits	
(Alwan	et	al.	2010).	Recent	work	by	the	Audit	
Commission	(2010)	found	large	variations	
in	inpatient	use	between	different	Primary	
Care	Trusts;	specifically	it	found	a	five-fold	
variation	in	admission	rates	for	psychosis,	
12-fold	variation	in	psychosis	bed	days	and	a	
14-fold	variation	in	length	of	stay.4	The	report	
estimated	that	if	all	trusts	achieved	the	median	
rate	of	bed	days	then	this	would	reduce	total	
bed	use	by	15%,	resulting	in	an	economic	
benefit	of	£221	million5	to	mental	health	
services.
DISRUPTED / LOSS  
OF EMPLOYMENT
Whilst	the	employment	rate	for	all	adults	
aged	16-64	years	in	England	is	currently	71%6,	
recent	estimates	place	the	employment	rate	
for	people	with	schizophrenia	as	between	
5	and	15%7	(Marwaha	&	Johnson	2004).	
Evidence	summarised	in	Figure	2	suggests	
that	the	employment	rate	for	people	with	
schizophrenia	has	fallen	significantly	over	the	
past	half	century	–	a	time	frame	over	which	the	
employment	rate	for	the	population	as	a	whole	
has	risen.	There	is	a	noticeable	lack	of	more	
recent	statistics	reporting	the	employment	rate	
for	people	with	schizophrenia	in	the	UK.
4. All rates weighted for need.
5. Updated to reflect current prices using the Pay and Prices Index in Curtis (2011).
6. Source: www.ons.gov.uk/ons/about-ons/who-we-are/services/unpublished-data/social-survey-data/aps/index.html
7. Estimates between 1990 and 2004.
Figure 2: Reported employment rates in 15 studies of people with schizophrenia 
in the UK; circle areas represent sample size. Data taken from Marwaha and 
Johnson (2004)
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The	exceptionally	low	employment	rate	
for	people	with	schizophrenia	represents	a	
huge	loss	of	productive	capacity.	Assuming	
an	employment	rate	of	7%	for	people	with	
schizophrenia	(the	weighted	average	of	
all	studies	since	1995)	and	an	employment	
rate	of	71%	in	the	general	population,	then	
schizophrenia	causes	–	or	is	associated	with	
–	a	64-percentage	point	decrease	in	the	
probability	of	being	competitively	employed.	
Using	an	estimate	of	gross	annual	median	
earnings	of	£21,3008	this	is	equivalent	to	
an	expected	loss	of	productive	capacity	
of	£13,600	per	year	per	individual	(2011/12	
price	levels).	The	use	of	mean	gross	annual	
earnings9	(£26,900)	gives	an	estimated	loss	of	
productive	capacity	of	£17,200	per	individual,	
which	can	be	scaled	up	to	give	an	expected	
loss	to	the	English	economy	of	£3.4	billion		
each	year.	
The	low	employment	rate	has	knock-on	effects	
on	the	finances	of	the	public	sector	through	
losses	in	tax	revenue	and	payments	of	social	
security	benefits.	Assuming	an	18%	average	
direct	tax	rate	(income	tax)	and	an	18%	average	
indirect	tax	rate	(VAT),10	this	translates	into	
£715	million	of	tax	revenue	forgone	(or	£5500	
per	service	user)	per	annum.
Low	rates	of	employment	also	translate	
into	higher	dependence	on	social	security	
benefits.	Updating	the	evidence	presented	
by	Mangalore	and	Knapp	(2007)	to	current	
prices	gives	an	estimated	receipt	of	benefits	
of	£5500	per	service	user	per	year	(assuming	
that	77.6%	of	economically	inactive	people	with	
schizophrenia	are	in	receipt	of	benefits).	If,	in	
the	absence	of	other	information,	we	assume	
that	the	same	proportion	of	the	general	
population	who	are	economically	inactive	are	
in	receipt	of	benefits	to	the	same	value,	we	
find	an	average	benefit	receipt	for	the	general	
population	of	around	£1900.	(This	is	likely	to	
be	an	over-estimate	since	most	members	of	
the	general	population	would	not	be	entitled	to	
incapacity	benefit.)	These	estimates	suggest	an	
excess	of	£3600	is	paid	in	benefits	per	service	
user	per	year,	or	a	total	of	£470	million	per	year.
Of	course	the	counterfactual	used	in	the		
above	scenario	is	unrealistic	–	even	the	most	
effective	interventions	in	schizophrenia	do	
not	produce	employment	rates	and	wage	
rates	on	a	par	with	the	average	for	the	general	
population	–	so	the	above	suggested	losses	in	
terms	of	tax	revenue	and	benefits	could	never	
be	fully	recovered.	However,	there	are	very	
significant	savings	that	could	be	made	if	the	
employment	rate	for	people	with	schizophrenia	
could	be	improved.	The	economic	gains	to	
society	resulting	from	a	cautious	scenario	
where	50%	of	people	with	schizophrenia	were	
employed	at	an	average	of	20	hours	a	week	
at	the	National	Minimum	Wage	would	be	in	
the	order	of	£350	million,	including	a	saving	of	
around	£120	million	to	the	public	finances.
There	is	no	evidence	to	suggest	that	
increasing	employment	rates	for	people	with	
schizophrenia	leads	to	detrimental	outcomes.	
Indeed	there	is	evidence	that	the	converse	
is	true,	that	successful	gain	of	competitive	
employment	by	individuals	who	want	it	(and	
the	vast	majority	do)	leads	to	improved	clinical	
outcomes	(Kilian	et	al.	2012).	This	improvement	
in	clinical	state	can	generate	knock-on	savings	
elsewhere,	for	example	in	health	service	costs.
DISRUPTED EDUCATION
Schizophrenia	most	often	develops	in	late	
adolescence	or	early	adulthood	–	years	that	
are	key	for	developing	skills	and	knowledge	
that	will	provide	benefit	and	increase	earnings	
potential	throughout	life.	The	debilitating	
nature	of	the	condition,	particularly	in	the	first	
few	years	after	onset,	often	forces	people	with	
schizophrenia	to	leave	education	or	training	
earlier	than	they	would	otherwise	have	done.	
Surprisingly	few	studies	have	addressed	the	
costs	of	missed	educational	and	training	
opportunities	due	to	the	condition.	
A	recent	report	for	the	department	of	Business,	
Innovation	and	Skills	found	that	the	marginal	
return	to	an	undergraduate	degree	was	27.4%	
(when	compared	to	having	two	or	more	
GCE	A	levels)	(London	Economics	2011b).	
8. Taken from the annual survey of hours and earnings (ASHE), 2011.  
Source: www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-235202
9. Taken from the annual survey of hours and earnings (ASHE), 2011.  
Source: www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-235202
10. The use of an indirect tax rate in this estimation accounts for the tax revenue forgone due to reduced consumer 
spending as a result of the fall in earnings. Rate taken from Adam and colleagues (2012).
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This	translated	into	a	lifetime	net	benefit	to	
the	individual	of	£108,000	(current	prices,	
discounted	at	3.5%	per	annum)	and	to	the	
exchequer	of	£89,000.	Thus,	for	every	young	
person	who	has	to	forgo	a	university	education	
because	of	schizophrenia	the	result	would	be	a	
lost	net	benefit	of	£197,000	to	society.	
Likewise,	for	many	young	people	the	
development	of	schizophrenia	means	they	
miss	vocational	education	and	training	
opportunities.	For	example,	if	a	young	person	
enrolled	for	a	BTEC	level	2	qualification	could	
not	complete	this	qualification	because	of	
developing	schizophrenia,	this	is	estimated	to	
result	in	forgoing	a	12%	wage	gain,	resulting	
in	a	forgone	net	benefit	to	society	of	between	
£54,000	and	£104,000	over	a	lifetime	(London	
Economics	2011a).
HOMELESSNESS
A	recent	naturalistic	study	found	that	33%		
of	a	sample	of	people	with	schizophrenia		
drawn	from	London	and	Leicester	had	been	
homeless	at	some	stage	and	13%	had	been	
roofless.	This	compared	to	figures	of	9%	and	
6%	for	France,	and	8%	and	3%	for	Germany	
(Bebbington	et	al.	2005).	Whilst	these	
figures	may	not	be	representative	of	the	UK	
more	widely,	since	large	conurbations	such	
as	London	and	Leicester	will	have	higher	
rates	of	homelessness	as	homeless	people	
from	other	areas	tend	to	drift	to	large	cities,	
they	do	suggest	major	failings	in	the	current	
systems	that	leave	large	proportions	of	
people	with	schizophrenia	highly	vulnerable	to	
violence,	theft,	substance	misuse	and	further	
deteriorating	mental	and	physical	health.	
Homelessness	represents	a	huge	waste	of	
potential	in	our	society.	Unemployment	is	both	
a	cause	and	consequence	of	homelessness.	
The	homeless	are	five	times	less	likely	to	be	
employed	than	the	population	as	a	whole	
(Crisis	UK	2012)	and	being	homeless	creates	
very	significant	barriers	to	subsequently	re-
entering	employment.	For	many	people,	being	
homeless	means	having	no	fixed	address	
for	mailings	and	not	being	able	to	open	a	
mainstream	bank	account,	making	it	harder	to	
find	work	(Stansbury	&	Phakey	2011).	
Homelessness	also	has	significant	direct	costs	
to	the	exchequer.	Estimates	of	the	(gross)	
annual	costs	of	homelessness	to	the	public	
sector	lie	between	£24,000	and	£30,000	per	
homeless	person	(Department	for	Communities	
and	Local	Government	2012).	It	is	not	easy	to	
attribute	costs	specifically	to	homelessness	as	
many	costly	phenomena,	such	as	substance	
misuse,	criminal	behaviour	and	poor	health,	
are	both	causes	and	results	of	homelessness.	
However,	it	is	clear	that	homelessness	is	not	
only	an	appalling	experience	for	an	individual,	
but	that	it	also	has	wide-ranging	economic	
consequences	for	them	and	society.
PHYSICAL HEALTH PROBLEMS
It	is	now	widely	recognised	that	schizophrenia	
increases	the	probability	of	poor	physical	
health	(Leucht,	et	al.,	2007).	As	a	result,	there	
is	a	significant	mortality	gap	between	people	
with	schizophrenia	and	the	general	population:	
a	recent	systematic	review	estimated	that	the	
age-adjusted	all-cause	mortality	rate	amongst	
people	with	schizophrenia	was	2.58	times	
higher	than	for	the	general	population	(Saha	
et	al.	2007).	A	proportion	of	this	elevated	
mortality	rate	is	due	to	an	increased	risk	of	
suicide,	but	individuals	with	schizophrenia	were	
found	to	have	increased	mortality	rates	in	most	
major	‘cause	of	death’	categories.	
Schizophrenia	increases	risk	factors	for	
many	physical	health	problems.	Analysis	
of	the	clinical	records	of	1.7	million	people	
found	that	61%	of	people	with	schizophrenia	
smoked	compared	to	33%	of	people	without	
schizophrenia,	and	that	33%	of	people	with	
schizophrenia	were	obese	compared	to	21%	of	
people	without	(Hippisley-Cox	&	Pringle	2005).	
Many	antipsychotic	medications	(particularly	
second	generation	ones)	are	associated	with	
weight	gain	(Connolly	2005).	Combined,	these	
factors	mean	that	people	with	schizophrenia	
face	a	higher	risk	of	developing	many	physical	
health	problems.
Until	fairly	recently	the	physical	health	of	
people	with	schizophrenia	has	not	been	a	
policy	priority	despite	this	very	substantial	
physical	health	inequality:	individuals	with	
schizophrenia	are	significantly	less	likely	to	
have	had	a	recent	cervical	smear,	a	recent	
blood	pressure	recording,	a	recent	cholesterol	
test	or	be	on	aspirin	as	a	prophylaxis	for	stroke	
12
(Hippisley-Cox	&	Pringle	2005).	There	are	also	
economic	arguments	to	be	made:	physical	
health	problems	translate	into	additional	
health	service	expenditure,	lost	productivity	
and	increased	reliance	on	social	care	services,	
resulting	in	significant	economic	losses.	
SUBSTANCE MISUSE
Quite	a	high	proportion	of	individuals	with	
schizophrenia	are	substance	misusers.	Data	
from	the	European	Schizophrenia	Cohort	
identified	an	overall	substance	dependence	
in	42%	of	participants	in	London	and	28.3%	in	
Leicester,	placing	the	two	UK	cities	first	and	
third	out	of	eight	European	cities	looked	at	
in	that	study	(Carrà	et	al.	2012).	That	study	
also	estimated	a	prevalence	rate	for	alcohol	
misuse	of	26.1%	compared	to	11.9%	in	the	
general	population,	and	a	prevalence	rate	for	
the	misuse	of	all	other	substances	of	17.8%	
compared	to	7%	for	the	general	population.	
Since	the	data	are	taken	from	urban	areas,	
figures	may	be	somewhat	higher	than	for	the	
country	as	a	whole	(Carrà	et	al.	2009),	but	it	is	
clear	that	there	is	a	strong	association	between	
schizophrenia	and	substance	misuse.	
In	addition	to	the	personal	costs	that	
substance	abuse	can	cause,	there	are	also	
wider	economic	consequences.	There	is	
evidence	that	individuals	with	a	dual	diagnosis	
of	schizophrenia	and	substance	misuse	incur	
higher	service	use	costs.	Turkington	and	
colleagues	(2009)	found	that	persistent	
substance	misuse	increased	the	probability	of	
relapse,	suggesting	additional	admissions	and	
service	costs.	McCrone	and	colleagues	(2000)	
found	that	in	a	sample	from	South	London,	
‘core’	costs	(mental	health	service	costs,	
emergency	clinic	costs	and	day	care	costs)	
over	a	six-month	period	were	£1913	higher	for	
the	dual	diagnosis	group	than	for	other	patients	
(95%	CI:	£309	to	£3865),	non-accommodation	
costs	were	£1910	higher	(95%	CI:	£281	to	
£3820)	and	total	costs	(including	supported	
accommodation)	were	£1469	higher	(95%	CI:	
-£954	to	£4292).	Whilst	there	are	problems	
of	self-selection	into	the	substance	misuse	
state	-	perhaps	individuals	with	more	severe	
psychosis,	who	would	incur	more	costs	anyway,	
are	more	likely	to	be	substances	misusers	
and	thus	the	above	costs	may	not	represent	
the	true	marginal	difference	in	costs	due	to	
substance	misuse	–	there	is	strong	evidence	
that	substance	misuse	is	associated	with	higher	
service	costs	in	schizophrenia	care.	
Another	cost	that	may	be	associated	with	
substance	abuse	for	people	with	schizophrenia	
is	because	of	crime.	In	a	large	longitudinal	
study	in	Sweden	(80025	people,	of	which	8003	
had	a	diagnosis	of	schizophrenia)	Fazel	and	
colleagues	(2009)	showed	that	the	elevated	
risk	of	someone	with	schizophrenia	committing	
a	violent	crime	can	be	almost	entirely	
accounted	for	by	high	levels	of	substance	
abuse	in	this	group.	
It	was	found	that	individuals	with	schizophrenia	
and	substance-use	co-morbidity	had	a	risk	of	
committing	a	violent	crime	that	was	4.4	times	
greater	(95%	CI:	3.9	to	5.0)	than	for	the	general	
population,	whereas	individuals	who	had	
schizophrenia	but	did	not	abuse	substances	
had	an	elevated	risk	of	just	1.2	greater	(95%	
CI:	1.1	to	1.4).	Similar	findings	were	found	in	a	
recent	systematic	review	(Fazel	et	al.	2009).	
Given	the	Home	Office	(2005)	estimates	that	
violent	crime	causes	economic	and	social	
costs	totalling	£44.6	billion11	in	England	and	
Wales	each	year,	elevated	violent	crime	due	to	
this	co-morbidity	between	schizophrenia	and	
substance	misuse	is	clearly	very	costly.
Other	costs	may	also	be	incurred	as	a	result	
of	a	dual	diagnosis	with	substance	misuse.	
It	is	likely	that	substance	misuse	reduces	
employment	opportunities,	resulting	in	wasted	
economic	potential	and	losses	to	the	exchequer	
in	tax	revenue	forgone.
 
11. Uprated to reflect current prices using the GDP deflator (ONS). 
12. Source: www.justice.gov.uk/downloads/statistics/mojstats/spcr-full-tables-paper-5-2-prisoners-backgrounds-
reconviction-a.xls
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CONTACT WITH THE  
CRIMINAL JUSTICE SYSTEM
People	with	schizophrenia	are	over-represented	
in	the	criminal	justice	system.	The	most	recent	
(although	now	quite	dated)	estimates	are	
that	around	8%	of	the	prison	population	has	
psychosis,	with	2%	qualifying	for	a	formal	
diagnosis	of	schizophrenia	(Singleton	et	al.	
1998).	This	compares	to	figures	of	between	
0.2%	to	0.5%	for	the	general	household	
population	(Singleton	et	al.	2000;	Saha	et	al.	
2005;	Mangalore	et	al.	2007).
Questions	are	increasingly	being	asked	about	
the	appropriateness	of	prison	sentences	for	
many	of	these	people	–	from	both	moral	and	
effectiveness	perspectives.	It	is	also	clear	that	
prison	may	be	an	economically	inefficient	
intervention	for	many	with	schizophrenia	or	
other	mental	health	problems.	The	cost	of	
a	prison	place	for	one	year	is	estimated	to	
be	£40,000	(Ministry	of	Justice	2011b)	and	
yet	it	is	remarkably	ineffective	at	preventing	
reoffending;	results	from	the	Surveying	
Prisoner	Crime	Reduction	survey12	found	that	
54.2%	of	prisoners	who	had	been	treated	for	a	
mental	health	/	emotional	problem	in	the	year	
before	custody	had	been	reconvicted	within	
one	year	of	release	(at	51.7%	the	reconviction	
rate	was	also	very	high	for	prisoners	without	
such	problems).	
Many	people	with	schizophrenia	who	have	
committed	crimes	end	up	in	secure	care	
provided	or	funded	by	the	NHS.	These	units	
are	different	from	prisons	because	of	their	
emphasis	on	care	and	treatment	as	opposed	to	
punishment.	There	are	a	number	of	routes	by	
which	an	individual	can	be	admitted	to	secure	
care:	they	can	be	referred	from	prison,	on	a	
restricted	or	unrestricted	hospital	order	from	
court	as	an	alternative	to	prison,	or	directly	
from	community	treatment.	Secure	mental	
health	beds	are	divided	into	high,	medium	
and	low	secure,	as	well	as	specialised	medium	
secure	units	for	women.	Nearly	97%	of	people	
transferred	on	restriction	orders	from	prison	
go	into	high	or	medium	secure	beds,	whereas	
low	secure	beds	are	mainly	used	for	people	
detained	directly	from	the	community	under	
the	Mental	Health	Act,	or	people	‘stepped-
down’	from	more	secure	beds	(Rutherford	&	
Duggan	2007).	
Secure	units	represent	a	very	expensive	
element	of	mental	health	care:	secure	and	
high-dependency	services	accounted	for	19%	
of	direct	investment	in	mental	health	services	
in	2010/11,	with	investment	totalling	over	
£1	billion	(Mental	Health	Strategies	2011).	In	
addition	to	high	unit	costs,	total	costs	are	so	
high	partly	because	stays	are	typically	very	
long,	with	27%	of	people	detained	remaining	in	
forensic	services	for	over	10	years	(Rutherford	
&	Duggan	2007).
FAMILY IMPACT
Many	relatives	and	other	unpaid	carers	
of	people	with	schizophrenia	will	give	up	
employment	or	take	time	off	work	in	order	to	
provide	care	and	support.	Using	results	from	
the	UK-SCAP	study,	Mangalore	and	Knapp	
(2007)	estimated	that	4.8%	of	carers	had	
terminated	employment	and	15.5%	took	a	mean	
of	12.5	days	off	work	per	year	specifically	as	
a	result	of	being	a	carer.	This	translates	into	a	
mean	annual	economic	loss	of	£517	(2011/12	
prices)	per	individual	with	schizophrenia	living	
in	the	household	population.
In	addition	to	the	loss	of	productivity	as	a	result	
of	being	a	carer,	it	is	also	possible	to	put	an	
economic	value	on	the	unpaid	care	that	these	
individuals	(who	are	usually	family	members)	
provide	to	people	with	schizophrenia,	on	the	
assumption	that	if	they	did	not	provide	such	
care	someone	else	would	have	to.	If	such	care	
and	support	is	valued	at	how	much	it	would	
cost	the	NHS	to	provide	similar	care	(the	salary	
of	an	assistant	nurse	or	nursing	auxiliary)	then	
based	on	the	assumption	that	the	unpaid	
carer	provides	a	mean	of	5.6	hours	support	
per	day,	this	comes	to	an	average	of	£34,000	
per	person	with	schizophrenia	being	looked	
after	by	a	family	or	other	carer.	Roughly	31%	of	
people	with	schizophrenia	are	living	in	private	
households	(Mangalore	&	Knapp	2007b),	so	
this	could	translate	into	an	aggregate	cost	to	
society	of	as	much	as	£1.24	billion	per	year.	
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Having	discussed	some	of	the	key	cost	drivers	in	relation	
to	schizophrenia,	we	now	move	on	to	look	at	the	economic	
consequences	of	a	variety	of	interventions.	The	extensive	
evidence	collected	by	the	Schizophrenia	Commission	
from	a	wide	range	of	people	with	expertise	about	and/
or	experience	of	psychosis	guides	the	scope	and	nature	
of	interventions	discussed	here.	In	gathering	and	collating	
economic	evidence	on	each	of	these	interventions	we	have	
tried	to	be	as	balanced	and	fair	as	possible.	
different	circumstances.	Interventions	are	
not	independent	from	one	another	in	that	
the	outcomes	of	one	may	be	positively	or	
negatively	impacted	by	other	interventions	
that	an	individual	is	receiving	or	has	previously	
received.	For	example,	it	would	perhaps	be	
unrealistic	to	assume	the	same	reduction	in	
inpatient	use	as	a	result	of	a	specific	talking	
therapy,	such	as	cognitive	behavioural	therapy	
(CBT),	when	the	individual	already	receives	
other	types	of	psychologically-informed	
interventions	as	when	he/she	receives	CBT	
alone.	Because	of	this	interdependence,	the	
cost	estimates	reported	here	are	in	certainly	not	
additive.	We	discuss	this	further	in	Section	3.	
Another	point	to	bear	in	mind	is	the	often	
elusive	nature	of	the	so	called	‘standard	care’	or	
‘treatment	as	usual’	against	which	interventions	
are	typically	compared.	Often	trials	give	limited	
information	about	the	nature	of	such	standard	
services	to	which	they	are	comparing	the	
intervention	in	question,	yet	since	standard	
practices	of	care	vary	tremendously	across	the	
country	(let	alone	between	countries	and	over	
time),	this	leads	to	serious	questions	about	
extrapolating	economic	evidence	from	one	
context	to	another.	If	a	particular	intervention	
saved	£X	per	patient	in	one	locality	when	
compared	to	standard	care	in	that	area,	it	is	
EVALUATING VARIOUS 
INTERVENTIONS
However,	due	to	time	constraints,	a	systematic	
review	in	each	case	was	certainly	not	
possible.	Instead,	as	a	starting	point	for	each	
intervention,	we	contacted	researchers	in	the	
area	to	identify	the	most	significant	existing	
economic	evidence,	including	extant	reviews.	
This	information	was	supplemented	with	
extensive,	albeit	not	systematic,	literature	
searching	for	each	intervention	in	turn.	
Where	the	economic	evidence	for	interventions	
was	considered	to	be	strong	we	have	
attempted	to	draw	conclusions	for	the	
economic	implications	of	these	interventions	
on	three	different	levels	–	for	the	NHS,	for	the	
public	purse	more	generally,	and	for	society	
as	a	whole.	For	those	interventions	where	
the	economic	evidence	is	not	strong	enough	
to	draw	firm	conclusions,	key	evidence	has	
been	summarised	and	areas	for	future	work	
highlighted.
Attention	must	be	drawn	to	the	fact	that	
these	interventions	are	neither	mutually	
exclusive	nor	independent.	Schizophrenia	is	a	
complex	condition	and	most	individuals	with	
the	condition	can	benefit	from	a	combination	
of	interventions,	and	of	course,	they	and	
their	families	would	have	preferences	about	
which	interventions	are	appropriate	in	
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not	necessarily	the	case	that	the	same	saving	
of	£X	will	be	obtained	in	another	locality	if	the	
standard	care	practiced	in	this	area	is	different.	
Having	said	that,	without	extensive	information	
about	the	routine	practice	of	different	mental	
health	services	there	is	often	little	option	but	
to	assume	a	similar	standard	care	and	thus	that	
any	costs	or	benefits	will	be	generalisable.	
Some	of	the	interventions	discussed	below,	
such	as	Early	Intervention	and	Crisis	Teams	are	
already	widely	in	place,	at	least	in	name;	and	
for	these	our	analysis	attempts	to	evaluate	the	
economic	evidence	for	maintaining	them.	Other	
interventions	discussed	here,	such	as	Individual	
Placement	and	Support,	Homelessness	
Interventions	and	Peer	Support	are	as	yet	not	
widely	available;	here	we	attempt	to	evaluate	
the	evidence	for	making	such	interventions	
more widely available.
All	costs	in	this	report	have	been	uprated	
for	inflation	to	2010/11	price	levels	using	
an	appropriate	price	index.	All	future	cost	
implications	have	been	discounted	back	to	the	
present	at	a	rate	of	3.5%	per	annum.
EARLY INTERVENTION
Some	early	intervention	services	(EIS)	in	
psychosis	aim	at	early	detection	of	people	
with	prodromal	symptoms	of	psychosis	(or	
those	whose	psychosis	has	not	already	been	
adequately	detected	and	treated),	but	most	
early	intervention	teams	are	working	with	
people	whose	illness	has	been	diagnosed.	
Treatment	in	the	early	intervention	stage	ideally	
involves	a	combination	of	‘pharmacological,	
psychological,	social,	occupational	and	
educational	interventions’	(National	Institute	
for	Health	and	Clinical	Excellence	2009).	The	
rationale	for	intervening	early	in	psychosis	is	
based	on	evidence	that	suggests	an	association	
between	the	duration	of	untreated	psychosis	
and	overall	prognosis	(Marshall	et	al.	2005).
Early	intervention	services	were	formally	
introduced	into	the	NHS	in	2001/2002	
as	outlined	in	The Mental Health Policy 
Implementation Guide	(Department	of	Health	
2001).	Since	then,	early	intervention	teams	have	
been	introduced	quite	widely	across	England	
(Shiers	&	Smith	2010)	although	there	remain	
inequalities	in	access	(IRIS	2011).
Clinical	evidence	suggests	Early	Intervention	in	
Psychosis	can	have	positive	effects.	A	recent	
systematic	review	and	meta-analysis	suggested	
that	specialised	First	Episode	Psychosis	
programmes	can	significantly	reduce	the	risk	
of	relapse	when	compared	to	usual	treatment	
(Alvarez-Jiménez	et	al.	2011).	A	recent	
Cochrane	review	was	less	positive,	finding	few	
significant	results	in	favour	of	EIS	(Marshall	
&	Rathbone	2011).	However,	the	usefulness	
of	the	Cochrane	methodology	in	evaluating	
service	models	such	as	Early	Intervention	has	
been	questioned.	McGorry	(2012)	claims	that	
many	well-designed	studies	evaluating	the	
effectiveness	of	EIS	were	excluded	from	the	
Cochrane	review.	He	disputes	the	relevance	
of	many	of	the	Cochrane	findings	since	‘the	
review	focused	largely	on	trials	comparing	the	
“component	interventions”	of	EIP	services.	
…	Such	interventions	were	typically	studied	
against	the	backdrop	of	the	range	of	care	
provided	within	streamed	EIP	services.	It	is	not	
surprising	that	some	of	these	individual	trials	
were	“ineffective”	given	that	the	control	groups	
in	these	trials	were	the	recipients	of	an	already	
comprehensive	model	of	care.’
In	addition	to	patient	outcomes	there	has	been	
attention	given	to	potential	cost	savings	that	
the	use	of	early	intervention	services	may	offer	
–	in	both	the	immediate	and	longer	term.	The	
first	studies	that	aimed	to	tackle	this	issue	were	
relatively	narrow	in	scope	–	focusing	largely	
on	direct	costs	to	mental	health	services.	
More	recently,	however,	work	has	been	done	
to	take	a	more	comprehensive	look	at	the	
economic	consequences	of	Early	Intervention	
services.	Recent	studies	have	considered	the	
implications	of	EIS	for	more	of	the	cost	drivers	
discussed	in	Section	1,	including	criminal	justice	
costs	and	lost	employment	costs	(McCrone	et	
al.	2010).
In	a	recent	economic	evaluation	of	EIS,	
McCrone	and	colleagues	(2010)	used	a	decision	
modelling	approach,	deriving	probabilities	
from	the	literature,	to	estimate	the	cost	
consequences	of	Early	Intervention	Services.	
The	results	were	strongly	in	favour	of	EIS.	This	
report	updates	the	costs	reported	by	McCrone	
et	al.	(2010)	so	they	reflect	current	costs	and	
prices,	and	also	adds	in	an	expected	increase	
in	tax	revenue.	Below	we	outline	the	key	
mechanisms	through	which	Early	Intervention	
Services	may	lead	to	cost	savings.
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Since	Early	Intervention	Services	have	been	
shown	to	have	clinical	benefits	it	is	perhaps	
unsurprising	that	their	introduction	would	
reduce	service	use,	in	particular	high-cost	
inpatient	time.	Indeed,	using	data	from	the	
Lambeth	Early	Onset	(LEO)	team,	routine	data	
from	Worcestershire	and	Northumberland	
EI	Services	and	the	Healthcare	Commission	
the	authors	(McCrone,	Knapp,	et	al.	2009)	
estimated	that	Early	Intervention	Services	
reduce	the	probability	of	a	formal	admission	
(compulsory	admission	under	the	Mental	Health	
Act)	from	44%	to	23%	in	the	first	2	months	of	
psychosis	and	from	13%	to	6%	in	each	2-month	
period	thereafter.	This	translates	into	very	
sizeable	cost	savings	for	the	mental	health	
services:	it	is	estimated	that,	at	2010/11	prices,	
the	introduction	of	an	Early	Intervention	Service	
saves	£5,493	per	service	user	in	the	first	year	
of	psychosis	and	£15,742	during	the	first	three	
years	(costs	discounted	at	3.5%	per	year).
Suicide and Homicide Costs
Early	Intervention	Services	have	been	shown	
to	be	effective	in	reducing	the	risk	of	both	
suicide	and	homicide.	Associated	cost	savings	
from	the	reduction	of	suicide	risk	(through	
costs	to	the	NHS	and	the	lost	productivity	of	
the	deceased)	are	estimated	at	£481	in	the	first	
year	of	psychosis.	The	associated	cost	savings	
from	the	reduction	in	homicide	risk	are	small	
(just	£28	over	three	years)	because	of	the	very	
low	starting	probability	that	a	service	user	
will	commit	homicide,	yet	Early	Intervention	
Services	do	significantly	reduce	this	risk.	
However,	we	need	to	be	cautious	with	these	
figures	on	suicide	and	(especially)	on	homicide	
given	the	limited	data	that	were	available	as	a	
basis	for	the	economic	calculation.
	
Earnings
Early	Intervention	Services	have	a	positive	
impact	on	the	retention	and	gain	of	competitive	
employment.	McCrone	et	al.	(2010)	estimate	
that	12%	of	standard	care	patients	will	be	in	
employment,	compared	to	35%	of	people	
supported	by	EIS.	If	a	human	capital	approach	
is	assumed,	valuing	employment	at	the	
minimum	wage	rate,	the	result	would	be	a	gain	
in	earnings	of	£4299	even	when	assuming	that	
no	employment	occurs	in	the	first	year	for	
either	group.	
This	increase	in	employment	rate,	when	
viewed	from	a	societal	perspective,	increases	
production	in	the	economy	as	a	whole	and,	
when	viewed	from	a	public	sector	perspective,	
increases	tax	revenue.	In	this	report	it	is	
assumed	that	the	only	net	benefit	in	terms	of	
tax	revenue	comes	from	the	mean	indirect	tax	
rate	of	18%	(Adam	et	al.	2012);	since	the	size	
of	the	earnings	we	are	considering	is	relatively	
modest,	we	assume	no	income	tax	is	paid,	
which	makes	the	estimates	of	cost	savings	to	
the	public	sector	conservative.
Net Cost Savings
When	we	sum	these	individual	costs	together	
to	find	the	net	savings	accrued	by	the	
introduction	of	EIS	we	find	the	following	
results:
	 The	introduction	of	Early	Intervention	
Services	is	estimated	to	save	the	National	
Health	Service	£5536	per	service	user	in	the	
first	year	of	psychosis.	This	rises	to	a	total	of	
£15862	in	the	first	three	years.
	 In	terms	of	the	public	purse	viewed	as	a	
whole,	the	introduction	of	EIS	is	estimated	
to	have	a	net	benefit	of	£5545	in	the	first	
year	of	psychosis,	rising	to	£16663	over	the	
first	three	years.	These	figures	include	costs	
accrued	to	the	NHS,	criminal	justice	system	
and	extra	tax	revenue	gained.
	 Taking	a	societal	view	of	the	net	benefits	
of	EIS	by	including	all	increased	production	
that	occurs	as	a	result	(not	only	that	which	
is	subsequently	collected	by	government	in	
taxes)	gives	a	figure	of	£6015	saved	in	the	
first	year	of	psychosis	and	£21512	saved	over	
the	three-year	period.
There	are	other	costs	that	have	not	been	
integrated	into	this	model	that	would,	it	
seems	likely,	increase	the	potential	savings	
of	EI	services.	One	is	the	cost	incurred	by	
families	and	carers	through	reducing	their	own	
employment	and	providing	unpaid	care	and	
support.	It	is	expected	that	through	the	clinical	
benefits	associated	with	EI,	this	cost	incurred	
by	families	would	be	reduced.
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The	above	estimates	of	cost	savings	from	
implementation	of	EIS	are	obtained	using	one	
specific	set	of	model	parameters:	a	specific	set	
of	probabilities	of	admission	under	standard	
care	and	EIS,	and	a	specific	set	of	costs	of	
admission	and	community	care.	Estimated	
cost	savings	from	the	implementation	of	EIS	
will	vary	from	locality	to	locality	depending	
on	prior	admission	rates,	the	fidelity	of	EIS	
to	evidence-based	models,	the	nature	and	
quality	of	‘standard	care’	services	and	the	
quality	and	cost	of	inpatient	care.	The	above	
model	is	largely	estimated	using	parameters	
taken	from	London-based	studies,	so	results	
may	not	be	immediately	transferable	to	other	
areas	of	the	country,	where	service	models	and	
populations	could	be	different.	However,	EIS	in	
very	different	parts	of	the	country	have	been	
successful	in	reducing	admissions.	For	example,	
following	the	implementation	of	the	North	
East	Derbyshire	Early	Intervention	service,	the	
percentage	of	people	with	schizophrenia	with	
a	first	episode	of	psychosis	(who	came	into	
contact	with	regular	services	and	the	specialist	
EIS	respectively)	that	were	admitted	to	hospital	
within	the	first	year	fell	from	62%	to	less	than	
31%	(Rowlands	2012;	Phillipson	et	al.	2012).13
When	considering	the	economic	consequences	
of	Early	Intervention	it	is	also	important	to	
bear	in	mind	that	schizophrenia	is	a	lifelong	
condition	and	the	benefits	of	the	specialised	
model	that	EIS	provides	may	not	be	sustained	
after	the	service	user	is	no	longer	eligible	for	
the	service.	In	two	major	studies,	significant	
benefits	of	EIS	were	no	longer	seen	at	a	five-
year	follow-up	(Gafoor	et	al.	2010;	Bertelsen	et	
al.	2008).	This,	though,	may	be	because	of	the	
services	that	recipients	of	EI	were	discharged	
to	rather	than	to	deficiencies	in	EI	itself.	
13. It must be noted that the eligible populations for the two services are different, mainly in that NE Derbyshire EIS only 
deals with people under the age of 35. Thus, whilst this figure is indicative of the success of EIS in bringing about 
fewer inpatient admissions it must not be interpreted as a precise estimate of the impact of the service.
Figure 3: Cost savings accrued through the introduction 
of Early Intervention Services (2010/2011 £)
8,000
7,000
6,000
5,000
4,000
3,000
2,000
1,000
0
Health	Service	Savings
Public	Sector	Savings
Societal	Benefit
N
et
	S
av
in
g
	/
	B
en
efi
t	
(2
0
11
/1
2	
£
)
Year
1 2 3
18
INDIVIDUAL PLACEMENT  
AND SUPPORT SCHEMES
Most	people	with	schizophrenia	and	other	
severe	mental	health	issues	want	to	work	
(Grove	1999;	Mueser	et	al.	2001;	Marwaha	
2005).	However,	only	between	5	and	15%	
are	actually	in	employment,	representing	a	
huge	waste	of	potential	as	well	as	denying	
people	opportunities	for	social	inclusion,	
meaningful	daytime	activity	and	a	sense	of	
personal	identity	and	achievement.	Individual	
Placement	and	Support	(IPS)	is	a	type	of	
supported	employment	aimed	at	helping	those	
with	severe	mental	health	problems	to	gain	
paid	competitive	employment.	IPS	services	
are	very	different	to	the	kinds	of	vocational	
rehabilitation	services	conventionally	available	
(and	the	services	that	still	exist	in	many	parts	
of	England)	in	that	IPS	services	aim	to	place	
people	with	schizophrenia	in	competitive	
employment	as	soon	as	possible	and	then	
provide	additional	support	and	training.		
In	contrast,	standard	vocational	schemes	
largely	take	the	approach	that	a	considerable	
amount	of	training	is	needed	before	people	
with	schizophrenia	are	ready	to	begin	
competitive	employment.	
Such	training	prior	to	obtaining	competitive	
employment	is	highly	expensive	and	has	
often	been	somewhat	ineffective	in	helping	
people	with	schizophrenia	gain	competitive	
employment	(Sainsbury	Centre	for	Mental	
Health	2009a;	Crowther	et	al.	2010).	There	
is	now	a	substantial	body	of	evidence	from	
across	the	world	that	IPS	is	significantly	more	
effective	at	helping	people	with	schizophrenia	
to	gain	competitive	employment	than	standard	
vocational	services	(Crowther	et	al.	2010)
The	detailed	characteristics	of	effective	IPS	
schemes	are	reported	elsewhere	(Becker	et	al.	
2008).	Below	are	listed	the	key	concepts	of	high-
fidelity	IPS	schemes	(copied	from	the	Sainsbury	
Centre	for	Mental	Health’s	report	(2009a):
	 Competitive	employment	is	the	primary	goal
	 Everyone	who	wants	it	is	eligible	for	
employment	support
	 Job	search	is	consistent	with	individual	
preferences
	 Job	search	is	rapid:	beginning	within		
one	month
	 Employment	specialists	and	clinical	teams	
work	and	are	located	together
	 Support	is	time-unlimited	and	is	individualised	
to	both	the	employed	and	the	employee
	 Welfare	benefits	counselling	supports	the	
person	through	the	transition	from	benefits	
to	work
Perhaps	the	most	obvious	public	sector	cost	
saving	that	we	might	expect	to	accompany	
the	implementation	of	IPS	services	is	the	
additional	tax	revenue	received	and	the	social	
security	benefit	payments	saved.	However,	
more	important	is	likely	to	be	the	reduction	in	
service	costs	resulting	from	the	improvement	in	
mental	health	that	competitive	employment	(or	
the	active	search	for	it)	can	bring.	IPS	services	
have	consistently	been	shown	to	have	very	
positive	outcomes	in	terms	of	clinical	measures.	
Meta-analysis	has	shown	that	IPS	schemes	
significantly	improve	symptoms	of	thought	
disturbance	(p=0.069),	anergia	(p=0.094)	
and	depression	(p=0.022)	and	improve	total	
symptoms	(p=0.009)14	(Campbell	et	al.	2011).
In	addition	to	the	better	documented	shorter	
term	effects	of	IPS	services	on	mental	
wellbeing	there	is	also	emerging	evidence	that	
there	are	very	significant	long-term	benefits	
associated	with	the	gain	of	stable	competitive	
employment	which	correspond	to	significant	
economic	savings	(Sainsbury	Centre	for	Mental	
Health	2009).
Much	of	the	evidence	on	the	economic	
consequences	of	IPS	schemes	is	somewhat	
limited,	with	many	studies	focusing	primarily	on	
savings	in	terms	of	increased	earnings	and	not	
considering	broader	cost	consequences.	
14. All symptoms measured using the Brief Psychiatric Rating Scale (BPRS)
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The	most	recently	published	economic	
evaluation	of	IPS	was	based	on	a	randomised	
controlled	trial	carried	out	in	six	European	
cities;	this	is	EQOLISE	study	(Burns	et	al.	2007;	
Knapp	et	al.	2012).	This	study	randomised	312	
participants	(around	80%	had	schizophrenia,	
others	had	bipolar	or	other	severe	mental	
health	problems)	to	either	IPS	services	or	
standard	vocational	services	and	followed	
them	for	18	months.	In	accordance	with	other	
studies	of	IPS,	largely	originating	from	the	
USA,	IPS	proved	much	more	effective	than	
standard	vocational	services,	both	in	terms	of	
gaining	competitive	employment	and	in	terms	
of	clinical	outcomes	(Burns	et	al.	2007;	Burns	et	
al.	2009;	Kilian	et	al.	2012)
The	economic	analysis	of	the	EQOLISE	study	
showed	encouraging	results	for	IPS	in	terms	
of	service	use	and	associated	costs	(Knapp	
et	al.	2012).	It	was	found	that	IPS	generated	
significant	savings	in	inpatient	costs,	a	saving	
of	£4,400	over	the	18-month	follow-up	period,	
although	most	of	this	saving	occurred	in	the	
first	six	months.	Effects	on	other	areas	of	
mental	health	service	costs	were	smaller:	IPS	
was	found	to	increase	outpatient	service	and	
community	service	costs	by	a	total	of	around	
£1,000	over	the	18	months,	whilst	effects	on	
other	areas	were	mixed.	Total	mental	health	
service	costs	(excluding	intervention	costs)	
were	£4,000	lower	for	the	IPS	group	compared	
to	the	vocational	services	group	over	the	
18-month	period.	
Earnings
Earnings	for	IPS	and	standard	care	were	
estimated	from	the	EQOLISE	study	using	
a	human	capital	approach.	Data	from	the	
EQOLISE	study	reveal	that	hours	worked	
increased	over	the	18-month	period	for	both	
the	IPS	and	the	comparison	groups,	but	IPS	
participants	worked	more	in	each	and	every	
period	with	the	difference	between	the	groups	
increasing	(see	Figure	4).	Reassuringly,	the	
estimated	hours	worked	from	the	EQOLISE	
study	were	very	similar	to	those	estimated	in	a	
recent	meta-analysis	of	four	high-quality	RCTs	
conducted	in	the	USA	(Campbell	et	al.	2011)	
which	together	included	681	participants.	It	
was,	however,	decided	to	use	data	only	from	
the	EQOLISE	study	since	UK	labour	markets	
are	more	similar	to	Europe	than	the	USA.	
15. This is an underestimate since a minimum wage rate was assumed for all participants whereas in reality some would 
be earning significantly more. Thus the actual benefit accrued to the exchequer is likely to be more than the figure 
estimated here.
Figure 4: Hours worked by IPS and standard Vocational Services 
participants (adapted from Burns et al 2007)
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This	increase	in	earnings	translates	directly	
into	societal	benefit	of	£1700	over	18	months	
(conservatively,	employment	was	valued	at	the	
national	minimum	wage	of	£6.08	per	hour).	
For	present	purpose,	to	create	an	estimate	
of	the	benefit	accruing	to	the	Exchequer	as	a	
result	of	this	increase	in	earnings,	an	average	
indirect	tax	of	18%	can	be	used,	resulting	in	an	
increased	revenue	of	£300	over	18	months	for	
the	Exchequer.	
Since	the	estimated	average	earnings	resulting	
from	IPS	are	relatively	small	–	only	eight	of	the	
312	EQOLISE	participants	were	estimated	to	
have	annual	earnings	above	the	lower	threshold	
for	income	tax	(£8105)15	–	no	increased	revenue	
due	to	income	taxes	or	national	insurance	
contributions	were	estimated.	
Other Economic Impacts
Analysis	of	the	cost	implications	of	IPS	
presented	in	this	report	covers	only	costs	
and	benefits	related	to	mental	health	service	
use	and	earnings.	We	have	not	attempted	
to	estimate	the	cost	consequences	of	any	
effect	that	IPS	might	have	on	physical	health,	
criminal	justice	contacts	or	housing	because,	
although	it	is	possible	that	these	effects	might	
result,	there	is	insufficient	robust	evidence	on	
them.	A	recent	meta-analysis	of	IPS	services	
in	the	USA	suggested	that	IPS	could	possibly	
reduce	homelessness	and	substance	abuse	
and	hence	generate	further	savings,	although	
the	results	of	the	met-analysis	were	positive	
but	not	statistically	significant.	Additionally,	
in	the	present	report	we	have	assumed	no	
reduction	in	benefit	receipt	resulting	from	IPS,	
whereas	in	reality	it	is	likely	that	benefit	receipt	
would	fall	with	the	increase	in	the	competitive	
employment	rate.	
Figure 5: Estimated cost savings per service user 
following the introduction of an IPS service
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Net Savings
Intervention	costs	were	taken	from	the	
London	site	of	the	EQOLISE	study.	In	reality,	
intervention	‘costs’	when	IPS	was	compared	
to	standard	vocational	services	were	actually	
negative	since	IPS	was	significantly	cheaper	to	
provide	than	these	standard	services.	Whilst	
this	may	not	represent	a	realistic	cost	saving	
for	mental	health	services	that	currently	offer	
little	or	no	vocational	services,	such	a	situation	
may	result	in	larger	savings	in	other	areas	as	
a	result	of	an	even	greater	differential	in	the	
employment	rate.	
Putting	together	these	various	cost	
components	we	arrive	at	estimated	net	savings	
per	service	user	of	implementing	an	IPS	
service:
	 The	introduction	of	Individual	Placement	and	
Support	Services	is	estimated	to	save	the	
National	Health	Service	£5193	per	user	of	the	
service	over	an	18	month	period.
	 It	is	estimated	that	the	introduction	of	IPS	
services	would	save	the	public	sector	as	a	
whole	£5501per	user	over	18	months	through	
reduced	health	service	costs	and	increased	
tax	revenue.
	 Taking	a	societal	view	the	net	benefits	of	IPS	
are	estimated	to	be	£6906	per	user	over	18	
months	which	includes	the	increase	in	total	
production,	not	just	the	component	collected	
in	tax	revenue	by	the	government.
These	net	savings	are	represented	in	Figure	5.
Figure	5	represents	estimated	cost	savings	
per	service	user	engaging	with	an	Individual	
Placement	and	Support	service.	The	EQOLISE	
study,	on	which	the	calculations	in	this	
report	are	based,	studied	only	people	with	
schizophrenia	who	wished	to	find	competitive	
employment	(Burns	et	al.	2007)	and	therefore,	
since	IPS	would	not	be	suitable	for	all	people	
with	schizophrenia,	it	is	difficult	to	calculate	
aggregate	savings	that	might	flow	from	the	
national	roll-out	of	IPS	services.
Caveats
Many	people	have	expressed	doubts	about	the	
applicability	of	IPS,	a	service	model	developed	
in	the	USA,	to	a	UK	context	(Heslin	et	al.	2011).	
They	argue	that	the	differing	structure	of	social	
security	and	the	labour	markets	means	that	IPS	
would	be	less	effective	in	the	UK	due	to	a	lesser	
necessity	to	find	work	in	order	to	survive	in	the	
USA.	This	argument	is	slightly	misleading,	since	
it	does	not	take	into	account	that	there	are	
also	major	economic	disincentives	to	regaining	
employment	in	the	USA	–	people	will	often	lose	
their	entitlement	to	programmes	like	Medicaid	
when	they	become	employed.	
There	are	legitimate	arguments	to	be	made	
about	the	differing	incentives	to	work	across	
nations,	but	the	overarching	premise	and	
motivation	of	an	IPS	approach	is	that	the	
majority	of	individuals	with	schizophrenia	
want	to	find	competitive	employment.	This	is	
often	not	only	(or	perhaps	at	all)	for	economic	
reasons,	and	gaining	such	competitive	
employment	is	clinically	beneficial.	However,	
some	results	do	suggest	that	the	work	
incentives	in	the	UK	are	such	as	to	discourage	
the	pursuit	of	competitive	employment	for	
individuals	with	schizophrenia.	In	the	EQOLISE	
study,	Burns	and	colleagues	(2007)	found	
that	London	was	at	the	highest	risk	out	of	
the	six	European	centres	of	having	a	benefit	
trap	despite	there	being	measures	in	place	to	
reduce	the	disincentives	for	work	(Sainsbury	
Centre	for	Mental	Health	2004).	Current	
reforms	to	social	security	entitlements	in	
England	might,	of	course,	reduce	any	financial	
disincentive	to	work.
FAMILY THERAPY
Family	therapy	refers	to	a	range	of	
psychosocial	interventions	for	people	who	
have	a	significant	emotional	connection	to	
someone	with	schizophrenia,	here	referred	
to	for	simplicity	as	‘the	family’.	The	therapy	
typically	involves	providing	information	about	
schizophrenia,	searching	for	methods	of	
supporting	an	individual	with	schizophrenia	
and	resolving	practical	problems.	Interventions	
are	aimed	at	reducing	the	level	of	expressed	
emotion	within	the	family,	since	expressed	
emotion	has	long	been	recognised	as	a	robust	
predictor	of	relapse	(Butzlaff	&	Hooley	2012).	
16. Uprated to reflect current prices using the GDP deflator, ONS.
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Although	family	therapy	has	been	an	accepted	
intervention	in	schizophrenia	treatment	for	a	
long	time,	relatively	few	studies	have	formally	
attempted	to	assess	its	economic	impact	
(Mihalopoulos	et	al.	2004;	Knapp	2000;	Leff	et	
al.	2001;	Goldstein	1996;	McFarlane	et	al.	1995;	
Tarrier	et	al.	1991;	Liberman	et	al.	1987).	In	this	
report,	we	base	our	economic	analysis	of	family	
therapy	primarily	on	a	recent	decision	model	
by	the	authors	of	this	report	(to	be	published	
separately).	This	model	uses	the	estimated	risk	
ratios	associated	with	the	probability	of	relapse	
with	family	therapy	derived	from	a	recent	
Cochrane	systematic	review	(Pharoah	et	al.	
2010)	to	update	probabilities	of	relapse	under	
standard	care	to	estimate	the	total	service	use	
costs	under	family	therapy	and	standard	care.	
The	model	estimates	a	cost	saving	(net	of	
intervention	cost)	of	£1,004	over	a	three-
year	period,	meaning	that	family	intervention	
would	be	seen	to	be	superior	to	standard	
care	in	that	it	is	associated	with	both	better	
clinical	outcomes	and	lower	costs.	In	sensitivity	
analysis	this	result	held	using	a	variety	of	
different	admission	costs.
CRIMINAL JUSTICE  
SYSTEM DIVERSION
	
Many	people	in	the	criminal	justice	system	
have	complex	mental	health	needs	which	are	
poorly	recognised	and	inadequately	managed.	
Large	numbers	end	up	in	prison:	a	high-cost	
intervention	which	is	inappropriate	as	a	setting	
for	mental	health	care	and	ineffective	in	
reducing	subsequent	offending.	The	overall	size	
of	the	prison	population	has	more	than	doubled	
in	the	last	20	years	and	one	prisoner	in	ten	has	
a	severe	mental	illness	such	as	schizophrenia.
Diversion	seeks	to	ensure	that	people	with	
mental	health	problems	who	come	into	contact	
with	the	criminal	justice	system	are	identified	
and	directed	towards	appropriate	mental	
health	care,	particularly	as	an	alternative	
to	imprisonment.	Diversion	can	be	within	
or	outside	the	justice	system	and	need	not	
replace	sanctions	for	any	offence	a	person	has	
committed.	
	
For	some	offenders	with	severe	mental	illness,	
the	most	appropriate	alternative	to	prison	is	
placement	in	an	NHS	secure	unit.	These	units	
are,	however,	intended	only	for	those	who	have	
committed	serious	offences	and	the	great	
majority	of	prisoners	with	severe	mental	illness	
are	on	short	sentences	and	have	not	committed	
serious	enough	crimes	to	warrant	transfer	to	a	
secure	hospital.	
About	three-quarters	of	all	people	sent	to	
prison	each	year	receive	sentences	of	less	
than	12	months	and	particularly	for	those	in	
this	group	with	severe	mental	illness	there	is	
a	strong	cost-effectiveness	case	for	the	use	
of	suspended	sentences	or	community	orders	
instead	of	imprisonment,	together	with	an	
appropriate	package	of	community-based	
mental	health	support.	
In	terms	of	costs	a	community	sentence	is	far	
cheaper	to	provide	than	a	prison	sentence.	
Figures	from	the	National	Audit	Office	
(Accenture	2007)	suggest	that	on	average	
a	community	sentence	costs	between	£720	
and	£4,10016	depending	on	its	type.	Even	the	
Mental	Health	Treatment	Requirement,	which	
is	the	most	expensive	of	the	twelve	community	
orders,	costs	only	roughly	10%	of	the	cost	of	
the	average	prison	sentence	(Ministry	of		
Justice	2011b).	
In	terms	of	effectiveness	too	it	appears	that	
community	sentences	dominate	prison	in	
the	outcomes	they	achieve	–	both	clinically	
and	in	reducing	reoffending.	People	with	
schizophrenia	can	get	much	better	mental	
health	care	in	the	community	than	in	prison:	
prison	is	a	very	poor	therapeutic	environment	
which,	if	anything,	is	likely	to	exacerbate	a	
mental	health	problem.	Since	the	people	for	
whom	community	orders	are	designed	are	
on	short	prison	sentences	(typically	less	than	
one	year)	they	are	unlikely	to	be	enrolled	on,	
or	benefit	from,	behavioural	programmes	
aimed	at	reducing	re-offending.	With	a	prison	
sentence	they	are	also	not	required	to	see	a	
probation	officer	after	release	which	means	
they	get	little	or	no	support	once	back	in	the	
community,	in	contrast	to	what	would	happen	
if	they	were	on	a	community	sentence.	Partly	
because	of	these	factors	re-offending	rates	
are	significantly	higher	on	a	like-for-like	basis	
comparing	people	on	a	short	prison	sentence	
and	those	on	a	community	sentence.	Indeed,	
17. The reports make detailed recommendations as to how MHTRs could be better implemented.
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using	a	matched	pairs	technique,	the	Ministry	
of	Justice	estimated	that	Community	Orders	
(of	all	types)	result	in	an	8	percentage	point	
decrease	in	re-offending	rates	when	compared	
with	custodial	sentences	of	less	than	one	year	
(Ministry	of	Justice	2011a).	
It	is	to	be	noted	that	there	is	no	strong	
argument	for	prison	sentences	over	community	
orders	on	public	safety	grounds	given	that	the	
type	of	offences	involved	are	relatively	minor.	
The	Mental	Health	Treatment	Requirement	
(MHTR)	is	one	of	the	twelve	requirements	
that	magistrates	and	judges	can	place	on	
individuals	who	receive	a	Community	Order	or	
a	Suspended	Sentence	Order.	The	requirement	
means	that	the	individual	is	then	required	to	
receive	mental	health	treatment	for	a	defined	
period	of	time.	Despite	its	introduction	in	2005,	
recent	data	from	the	Ministry	of	Justice	show	a	
very	low	uptake	of	the	requirement.	Whilst	43%	
of	people	serving	community	sentences	have	
some	sort	of	mental	health	problem	(Solomon	
&	Silvestri	2008),	only	0.3%	are	given	a	Mental	
Health	Treatment	Requirement.	Barriers	
to	more	widespread	use	of	MHTRs	include	
difficulties	in	obtaining	psychiatric	assessments,	
ineffective	identification	of	mental	health	
problems	in	the	criminal	justice	system,	a	
lack	of	awareness	of	the	requirements	within	
the	criminal	justice	system	workforce	and	a	
lack	of	communication	and	trust	between	
health	services	and	the	criminal	justice	system	
(Khanom	et	al.	2009;	Seymour	et	al.	2008).17
It	is,	however,	important	to	emphasise	that		
the	case	for	diversion	for	people	with	
schizophrenia	does	not	stand	or	fall	depending	
on	whether	or	not	they	get	an	MHTR.	If	an	
MHTR	is	deemed	to	be	unsuitable,	perhaps	
because	of	an	inappropriateness	of	providing	
treatment	on	a	compulsory	basis,	the	cost-
effectiveness	case	for	the	diversion	of	people	
with	schizophrenia	out	of	prison	and	into	the	
community	still	stands.
PHYSICAL HEALTH
As	discussed	in	Section	1.5,	the	physical	
health	of	individuals	with	schizophrenia	and	
the	associated	economic	consequences	
have	long	been	overlooked.	Interventions	
for	schizophrenia	are	rarely	analysed	from	a	
physical	health	perspective;	the	in-depth	cost-
consequence	analysis	of	the	antipsychotic	
Figure 6: Mean Differences in change in body weight between the 
treatment and control groups. End of treatment results include follow up, 
up to 6 months (95% CI in parentheses). Source: Faulkner et al. (2010)
Cognitive	/	Behavioural	
Intervention
Pharmacological	Intervention
Preventing	Weight	Gain
Medium	term:
-3.38kg	
(-4.81kg	to	-1.96kg)
End	of	treatment:
-4.87kg	
(-7.11kg	to	-2.64	kg)
End	of	treatment:
-1.16kg	
(-1.90kg	to	-0.41	kg)
Treating	Weight	Gain
Medium	term:
-1.69kg	
(-2.77kg	to	-0.61kg)
End	of	treatment:
-3.85kg	
(-4.25kg	to	-3.44kg)
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medication	aripiprazole	which	took	into	
account	risks	of	diabetes	and	cardio-vascular	
disease	undertaken	by	Barnett	and	colleagues	
(2009)	is	a	rare	exception.	It	is	important	that	
physical	health	implications	of	all	treatments	
be	routinely	considered	in	analyses	that	inform	
policy	decisions.	Below	we	discuss	evidence	
on	interventions	that	are	specifically	designed	
to	target	the	physical	health	of	individuals	with	
schizophrenia.
Interventions to reduce weight 
Responding	to	higher	than	usual	levels	of	
overweight	and	obesity	amongst	individuals	
with	schizophrenia,	a	range	of	interventions	
have	been	devised	which	aim	to	reduce	
weight	(either	prevent	weight	gain	or	treat	
weight	gain).	Such	interventions	can	fall	into	
the	broad	categories	of	cognitive-behavioural	
interventions	that	work	through	changing	
lifestyle	choices	and	pharmacological	
interventions.	
A	recent	Cochrane	review	(Faulkner	et	al.	2010)	
of	such	interventions	found	that	both	types	
of	interventions	(within	which	there	are	many	
different	specific	interventions)	were	effective	
both	at	preventing	and	treating	weight	gain	
in	the	short	to	medium	term.	Figure	6	offers	a	
summary.	
Even	when	there	is	significant	weight	reduction	
in	the	short	run	it	is	very	difficult	to	draw	
conclusions	about	the	economic	impact	of	such	
interventions.	There	is	little	evidence	with	which	
to	determine	whether	or	not	any	reduction	in	
weight	is	sustained	into	the	longer	run.	Since	
many	of	these	interventions	are	designed	
to	be	administered	in	the	early	stages	of	
schizophrenia,	the	participants’	risk	of	suffering	
a	major	physical	health	event	(such	as	a	heart	
attack	or	stroke)	is	small	in	the	short	term,	and	
so	even	if	a	reduction	of	weight	occurs	this	may	
be	of	little	importance	in	increasing	overall	life	
expectancy	if	weight	reduction	is	not	sustained.	
Thus,	to	fully	understand	the	economic	
consequences	of	interventions	that	aim	to	
reduce	weight	in	people	with	schizophrenia,	
more	research	is	needed	looking	at	the	extent	
to	which	weight	loss	is	sustained.18
Exercise Therapy
Exercise	therapy	is	an	intervention	that	is	
sometimes	used	with	the	aim	of	increasing	
mental	and	physical	wellbeing.	Clinical	
outcomes	reported	in	a	recent	Cochrane	review	
(Gorczynski	&	Faulkner	2011)	were	generally	
positive,	recording	significant	improvements	
in	measures	of	mental	health	and	physical	
fitness.	However,	the	limited	number	of	studies	
addressing	Exercise	Therapy	as	a	treatment	in	
schizophrenia	and	the	lack	of	evidence	as	to	
how	changes	in	physical	fitness	translate	into	
economic	consequences	means	that	no	more	
analysis	is	possible	here.	
Smoking Cessation
As	discussed	in	Section	1.5,	schizophrenia	is	
associated	with	almost	a	doubling	of	the	risk	of	
tobacco	use,	which	in	turn	has	many	adverse	
affects	on	physical	health.	In	response,	a	variety	
of	interventions	have	been	conceptualised	
in	order	to	help	people	with	schizophrenia	
stop	smoking,	many	of	which	are	based	on	
interventions	that	have	previously	been	shown	
to	be	effective	for	the	population	as	a	whole.	In	
a	recent	Cochrane	review,	Tsoi	and	colleagues	
(2010)	found	evidence	to	suggest	that	the	
antidepressant	bupropion	could	be	effective	
at	helping	people	to	quit.	However,	too	little	
evidence	was	found	in	our	review	to	draw	any	
meaningful	conclusions	about	the	effects	of	
other	treatments	such	as	nicotine	replacement	
therapy	and	psychosocial	interventions.	
In	terms	of	cost-effectiveness	evidence,	
little	analysis	has	specifically	addressed	the	
question	of	whether	interventions	designed	
to	help	people	with	schizophrenia	to	stop	
smoking.	One	recent	analysis	used	a	Markov	
model	to	consider	the	economic	implications	
of	ten-week	intervention	of	bupropion	and	
co-interventions	(group	therapy	either	alone	
or	win	combination	with	nicotine	replacement	
therapy)	and	compared	this	to	co-interventions	
only.	The	model	estimated	that	the	incremental	
cost-effectiveness	ratio	of	the	combined	
intervention	was	£385	per	QALY,	well	below	
NICE’s	recommended	threshold	for	cost	
effectiveness.	The	model	predicted	that	
there	was	a	95%	chance	that	the	combined	
intervention	was	more	cost-effective	than	the	
co-interventions	only	(Winterbourne	2012).
18. Current research in PSSRU at the LSE is looking at the economic case for weight loss/avoidance interventions for 
people in the early stage of their psychosis. 
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SUBSTANCE MISUSE
As	discussed	in	Section	1.8,	substance	misuse	
amongst	people	with	schizophrenia	has	
significant	adverse	economic	consequences,	in	
part	through	inflating	NHS	costs	and	criminal	
justice	system	costs.	The	complex	needs	of	this	
population	are	increasingly	being	recognised;	
NICE	has	recently	published	a	guideline	on	
assessing	and	managing	‘psychosis	with	co-
existing	substance	misuse’.	Clinical	practice	
recommendations	by	NICE	address	many	
broad	areas	to	equip	mental	health	and	
substance	misuse	services	to	work	effectively	
with	people	who	fall	under	the	remit	of	both	
services.	Here,	we	summarise	the	available	
economic	evidence	on	psychological	and	
psychosocial	interventions	that	have	been	
specifically	designed	for	a	population	with	co-
existing	schizophrenia	and	substance	misuse.
A	variety	of	psychological	and	psychosocial	
interventions	are	recommended	for	p	
eople	with	one	of	schizophrenia	or	substance	
misuse,	but	some	evidence	suggests	that	
individuals	with	a	dual	diagnosis	can	be	
excluded	from	these	interventions	(in	
particular,	many	do	not	receive	any	treatment	
for	substance	misuse)	(Department	of	
Health	2006).	Therefore	psychological	and	
psychosocial	interventions	have	been		
designed	specifically	for	this	population	
with	a	dual	diagnosis;	these	interventions	
generally	involve	some	combination	of	CBT	and	
motivational	interviewing.	
The	clinical	outcomes	recorded	by	meta-
analyses	in	a	recent	Cochrane	review		
(Cleary	et	al.	2010)	and	by	NICE	(2011)	are	
mixed,	with	some	evidence	of	significant	
improvements	in	substance	misuse	and	mental	
health,	although	many	measures	showed	
no	significant	difference.	Sample	sizes	were	
generally	small,	as	were	the	number	of	relevant	
studies	available.	
One	randomised	trial	has	attempted	to	study	
the	economic	consequences	of	an	intervention	
that	combined	CBT,	family	intervention	
and	motivational	interviewing	(Haddock	
2003).	A	wide	range	of	costs	was	taken	into	
account,	including	health	service	costs,	travel	
costs,	productivity	losses	and	out-of-pocket	
expenditures.	Net	of	intervention	costs	(the	
intervention	cost	£281319	over	an	18	month	
period)	it	was	found	that	mean	total	costs		
were	£1627	lower	(p=0.25)	for	the	intervention	
group	than	for	the	control	group	(95%	CI:	
£9012	less	to	£5759	more).	Net	of	intervention	
costs,	mean	costs	incurred	by	the	health	
service	were	£1554	lower	for	the	intervention	
group.	The	authors	estimated	that	there	was	a	
69.3%	chance	that	the	intervention	was	cost-
saving	(a	willingness	to	pay	of	zero).	If	the	
favourable	clinical	results	produced	by	the	
intervention	were	given	value,	the	probability	
of	the	intervention	being	cost-effective	
would	increase.	Whilst	this	study	shows	some	
promising	results	for	such	interventions,	the	
small	sample	size	and	lack	of	other	similar	trials	
mean	caution	must	be	applied.
HOMELESSNESS- 
TARGETED INTERVENTIONS / 
SUPPORTED HOUSING
As	discussed	in	Section	1.4,	people	with	
schizophrenia	in	the	UK	are	highly	vulnerable	
to	becoming	homeless,	with	major	implications	
for	their	mental	and	physical	well-being,	
and	for	direct	service	costs,	as	well	as	
representing	a	huge	waste	of	economic	
potential.	In	recognition	of	this	problem	a	
variety	of	different	interventions	have	been	
conceptualised	which	aim	to	reduce	the	
incidence	of	homelessness	amongst	people	
with	severe	mental	illness.
	
Critical Time Interventions
A	Critical	Time	Intervention	(CTI)	is	‘an	
individual-level	intervention	designed	to	reduce	
the	risk	of	homelessness	and	other	adverse	
outcomes	in	adults	with	mental	illness	following	
discharge	from	institutions	to	community	
living’	(Herman	et	al.,	2007).	Such	interventions	
typically	last	around	9	months	and	consist	of	
three	phases	–	the	transition	phase,	the	try-
out	phase	and	the	transfer	of	care	phase.	A	
CTI	worker	oversees	the	whole	intervention	
and	performs	key	roles	including	home	visits,	
co-ordinating	care-givers	(meeting	with,	
giving	advice	to	and	mediating	conflicts)	and	
developing	plans	for	long-term	goals	(Herman	
et	al.,	2007).	
19. Updated to reflect current prices using PSSRU’s Pay and Prices Index. 
20. Figure converted from US$ using PPP rates in 1992 and then uprated for inflation using the GDP deflator.
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A	randomised	controlled	trial	to	examine	
the	effectiveness	and	cost-effectiveness	of	
CTI	was	carried	out	with	a	sample	of	96	men	
discharged	from	a	shelter	in	New	York	City	
between	1991	and	1993.	This	study	showed	
the	CTI	group	experienced	significantly	fewer	
nights	of	homelessness	as	compared	to	the	
control	group	(p=0.003)	and	significantly	
fewer	periods	of	extended	homelessness	(over	
54	nights)	(p=0.45)	(Susser	et	al.	1997).	A	re-
analysis	of	the	data	also	suggested	a	significant	
reduction	in	chronic	homelessness	(Lennon	et	
al.,	2005).	A	cost-effectiveness	analysis	of	the	
same	trial	revealed	that	mean	costs	(including	
intervention	costs,	mental	health	care,	other	
health	care,	acute	services,	substance	abuse	
services,	housing	services,	criminal	justice	and	
public	transfers)	were	broadly	similar	across	
the	two	groups:	costs	incurred	by	the	CTI	
group	were	1.4%	higher	than	those	incurred	by	
the	controls.	
The	cost	of	the	intervention	was	almost	offset	
by	a	reduction	in	service	use	(in	particular	in	
acute	services,	supported	housing,	shelter	
services).	The	authors	concluded	that	a	
willingness	to	pay	of	more	than	£14720	per	
non-homeless	night	made	CTI	a	cost-effective	
intervention.	This	suggests	CTI	could	possibly	
be	a	cost-effective	intervention	in	the	UK	too,	
although	more	work	would	need	to	be	done	to	
see	how	such	interventions	could	be	adapted	
to	a	UK	context.	
A	recent	RCT	has	compared	outcomes	
following	discharge	from	a	psychiatric	hospital	
in	New	York	City	of	a	group	receiving	a	
9-month	CTI	service	in	addition	to	usual	care	
and	a	control	group	receiving	only	usual	care.	
This	study	estimated	that	the	CTI	service	led	to	
a	five-fold	decrease	in	the	risk	of	homelessness	
(Odds	ratio:	0.22,	95%CI:	0.06,0.88)	(Herman	
et	al.	2011).	Whilst	this	study	makes	no	mention	
of	service	use	or	the	costs	of	providing	CTI,	
such	a	dramatic	reduction	in	homelessness	
suggests	this	is	an	important	intervention	to	
consider.	
Although	no	data	are	yet	available,	a	study	led	
by	the	University	of	Manchester	is	currently	
evaluating	CTI	for	people	with	mental	health	
problems	released	from	prison,	
	
Assertive Community Treatment
Assertive	Community	Treatment	(ACT)	refers	
to	an	outpatient	service	model	grounded	on	
a	mobile	team	delivering	psychiatric	care	and	
case	management	to	people	with	schizophrenia	
who	make	intensive	use	of	inpatient	services.	
The	approach	was	not	designed	specifically	to	
address	the	issue	of	homelessness	amongst	
people	with	severe	mental	illness,	although	
it	has	been	suggested	that	ACT	may	be	an	
effective	intervention	to	tackle	the	issue.	
Wolff	and	colleagues	(1997)	conducted	a	cost-
effectiveness	analysis	of	an	RCT	examining	
the	effect	of	providing	three	forms	of	case	
management	to	individuals	with	severe	
mental	illness	who	were	either	homeless	or	
at	risk	of	homelessness	from	St.	Louis.	Whilst	
ACT	services	did	not	significantly	reduce	the	
incidence	of	homelessness	the	authors	did	
find	that	there	was	no	significant	difference	
in	total	costs	incurred	(a	reduction	in	service	
use	largely	offset	higher	intervention	costs	of	
ACT)	and	an	improvement	in	symptoms	and	
satisfaction,	indicating	ACT	may	be	a	cost-
effective	intervention	for	delivering	mental	
health	services	to	the	homeless.	Another	
RCT	studying	the	outcomes	of	providing	
ACT	to	homeless	people	with	severe	mental	
illness,	this	time	in	Baltimore,	found	positive,	
but	largely	insignificant,	effects	on	housing	
outcomes	(Lehman	et	al.	1997).	This	study	
suggested	net	savings	from	the	implementation	
of	an	ACT	service:	mean	cost	per	case	(net	of	
intervention	costs)	was	found	to	be	24%	lower	
for	the	ACT	group	than	the	control.	Whilst	
these	two	studies	do	provide	supporting	
evidence	for	the	premise	that	ACT	is	a	cost-
effective	intervention	for	homeless	people	with	
severe	mental	illness,	Rosenheck	(2000)	has	
questioned	the	generalizability	of	findings	since	
both	studies	had	patients	who	incurred	much	
higher	costs	(at	baseline)	than	the	US	national	
average	and	thus	it	may	be	easier	to	prove	
cost-effectiveness	or	cost-neutrality.	
A	recent	large-scale	(non-randomised)	study	
of	ACT	in	the	USA	suggested	that	ACT	did	not	
significantly	(in	the	matched	sample)	reduced	
homelessness	yet	caused	a	net	increase	in	
costs,	thus	questioning	whether	this	is	the	
most	effective	way	with	which	to	deal	with	the	
problem	of	homelessness	amongst	people	with	
schizophrenia	(Slade	et	al.	2012).
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The	above	studies	were	all	conduced	in	the	
USA	and	the	first	two	are	now	quite	dated,	
meaning	questions	must	be	asked	about	the	
relevance	of	these	findings	for	the	UK	today.	
The	most	recent	RCT	studying	high-fidelity	
ACT	in	the	UK	found	no	reduction	in	service	
use	for	ACT	service	users	-	indeed	total	in-
patient	days	were	higher	(but	insignificant)	for	
the	ACT	group	than	for	the	community	mental	
health	team	group	(Killaspy	et	al.	2009).	Whilst	
the	study	did	not	report	on	homelessness	
directly,	it	raises	questions	about	the	added	
benefit	that	ACT	services	bring	above	and	
beyond	Community	Mental	Health	Teams	in	a	
UK	context,	not	least	because	many	‘standard’	
community	services	now	embody	the	principles	
of	assertive	outreach	(Burns	et	al	2001).
Outreach Programmes
Outreach	programmes	aim	to	improve	
outcomes	for	homeless	people	with	mental	
illness	by	engaging	with	homeless	people	who	
are	unwilling	to	find	help	on	their	own	and	
providing	help	to	such	groups.	
The	only	outreach	programme	evaluated	
with	an	experimental	design	is	the	New	York	
Choices	programme.	This	consisted	of	four	
main	elements:	(1)	outreach	and	engagement,	
(2)	invitation	to	the	Choices	Centre,	(3)	respite	
housing,	and	(4)	in-community	and	on-site	
rehabilitation	services	(Shern	et	al.	2000).	By	
using	available	service	use	data,	Rosenheck	
(2000)	estimated	that	the	service	increased	
costs,	both	through	the	additional	intervention	
costs	and	through	increased	service	use	costs	
as	more	people	were	brought	into	services.	
Similarly,	by	estimating	the	cost	implications	
from	service	utilisation	data,	Rosenheck	(2000)	
estimated	that	the	Access	to	Community	Care	
and	Effective	Supportive	Services	Program	
(Lam	&	Rosenheck	1999)	was	a	cost-increasing	
intervention	but	was	effective	in	improving	
access	to	housing	and	improving	symptoms.	
Likewise,	an	observational	study	of	the	
Department	for	Veteran’s	Affairs	veteran’s	
program	showed	health	care	costs	(both	
inpatient	and	outpatient)	increased	significantly	
with	outreach	contact,	with	an	observed	
increase	in	health	care	costs	of	13%.	When	the	
costs	of	the	intervention	are	also	added,	the	
observed	increase	in	costs	in	the	year	after	first	
outreach	contact	was	36%	(Rosenheck	et	al.	
1993).
By	the	definition	of	outreach,	these	
programmes	very	often	bring	people	into	
contact	with	services	who	may	not	otherwise	
have	been	so,	and	thus	may	well	increase	
service	use	costs	as	well	as	improving	
outcomes.	This	does	not	mean	these	
programmes	are	not	cost-effective,	but	their	
cost	effectiveness	lies	in	the	balance	of	the	
extra	costs	they	incur,	the	improvement	in	
outcomes	and	the	value	society	places	on	
those	improvements.
	
Supported Housing
Supported	housing	for	people	with	
schizophrenia	is	seen	as	a	crucial	component	
of	care	for	those	who	may	not	be	able	to	live	
independently	in	the	community	(Lelliott	
et	al.	1996;	Priebe	et	al.	2009).	High-quality	
supported	housing	interventions	may	reduce	
the	number	of	people	with	schizophrenia	
who	become	homeless	(Macpherson	2004).	
Surprisingly	very	few	high-quality	studies	
have	attempted	to	address	the	implications	
of	supported	housing	for	people	with	
schizophrenia	(or	severe	mental	illness	in	
general).	Indeed,	a	recent	Cochrane	review	
on	the	subject	found	that	no	studies	met	their	
inclusion	criteria	(Chilvers	et	al.	2010).
Studies	have	addressed	the	issue	but	given	
their	methodological	weaknesses	results	
must	be	interpreted	with	caution.	One	
study	in	Boston,	Massachusetts	randomised	
participants	to	either	Evolving	Consumer	
Households	(where	people	with	schizophrenia	
lived	in	groups	and,	in	the	early	stages,	had	
much	support	from	programme	workers)	
or	Independent	Living	apartments.	Housing	
and	clinical	outcomes	were	not	significantly	
different	between	the	two	groups,	but	costs	for	
the	Evolving	Consumer	Households	group	were	
much	greater	due	to	the	additional	housing	
costs	(Dickey	et	al.	1997;	Rosenheck	2000).	
An	observational	study	of	the	Department	for	
Veteran’s	Affairs	Homeless	Chronically	Mentally	
Ill	Veterans	Program	in	which	homeless	people	
with	mental	illness	were	given	time-limited	
treatment	in	a	halfway	house	suggested	that	
residential	treatment	led	to	superior	outcomes	
21. Uprated to reflect current prices using PSSRU’s Pay and Prices Index
22. Uprated to reflect current prices using PSSRU’s Pay and Prices Index.
23. All costs uprated to reflect current prices using PSSRU’s Pay and Prices Index.
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but	increased	costs:	mean	costs	for	the	
residential	treatment	group	were	53%	higher	
than	for	the	case	management	group	(Lipton	et	
al.	1988;	Rosenheck	2000).	
The	evidence	on	the	cost-effectiveness	of	
supported	housing	interventions	in	the	context	
of	tackling	homelessness	is	mixed.	There	is	a	
need	for	robust	studies	in	this	area.	
CRISIS TEAMS
Crisis	Resolution	Home	Treatment	(CRHT)	
teams	were	established	in	the	NHS	following	
their	recommendation	in	the	National	Service	
Framework	in	1999	(Department	of	Health	
1999).	The	aim	of	these	teams	is	to	provide	
intensive	treatment	and	support	in	the	
community	to	those	undergoing	a	severe	
mental	health	crisis	that	would	otherwise	result	
in	admission	to	an	inpatient	unit.	Effective	
CRHT	teams	reduce	inpatient	usage,	both	
through	reducing	the	probability	that	an	
admission	would	occur	(acting	as	a	so	called	
“gatekeeper”)	and	by	allowing	for	earlier	
discharge.
Studies	suggest	savings	can	be	made	from	
CRHT	teams	when	they	are	implemented	with	
high	fidelity.	A	prospective	non-randomised	
study	compared	service	costs	of	patients	
before	and	after	the	implementation	of	a	CRHT	
team	in	South	Islington	(McCrone	et	al.	2009).	
It	was	found	that	mean	costs	for	the	cohort	
following	the	implementation	of	the	Crisis	
Resolution	team	were	£173821	lower	than	before	
the	service,	although	this	difference	was	not	
statistically	significant.	A	subsequent	economic	
evaluation	alongside	a	randomised	controlled	
trial	examining	the	effects	of	a	Crisis	Resolution	
Team	in	North	Islington	found	that	mean	total	
service	use	costs	were	£252022	(90%	CI:	£969	
to	£4054)	lower	for	those	randomised	into	the	
CRT	group	(McCrone	et	al.	2009a).
However,	studies	looking	at	the	effects	of	
the	implementation	of	CRHT	teams	as	they	
have	been	implemented	and	are	working	in	
practice	have	been	slightly	more	mixed.	An	
initial	analysis	showed	a	positive	effect	on	
inpatient	admissions	with	admissions	falling	by	
an	average	of	10%	(95%	CI:	1.7%	to	18.1%)	more	
in	the	34	areas	which	had	had	CRHT	teams	
in	place	for	the	past	two	years	and	by	23%	
(95%	CI:	7.1%	to	38.4%)	more	in	the	12	areas	
which	operated	24	hours	a	day,	compared	with	
the	130	areas	without	CRHT	teams	(Glover	
et	al.	2006).	However,	reanalysis	of	the	same	
admission	data	reached	a	different	conclusion.	
The	reanalysis	used	a	difference-in-difference	
model	and	controlled	for	confounding	variables	
such	as	deprivation,	substance	misuse,	age,	
gender,	population	density,	region,	length	
of	stay	and	fidelity	of	services.	The	CRHT	
indicator	variable	was	not	significant.	This	
analysis	led	the	authors	to	the	conclusion	that	
the	implementation	of	a	CRHT per se did	not	
decrease	admission	rates	(Jacobs	&	Barrenho	
2011).	However,	this	perhaps	reflects	the	fact	
that	while	inpatient	use	for	those	receiving	
CHRT	input	falls,	bed	use	for	an	area	may	be	
maintained	due	to	the	existence	of	excess	
demand.	
Earlier	work	by	the	National	Audit	Office	
(2007)	suggested	that	while	CRHT	teams	
were	having	a	positive	impact	on	inpatient	
bed	use,	teams	were	often	not	utilised	to	their	
full	potential.	The	survey	of	500	admissions	
they	carried	out	suggested	that	only	half	
(as	opposed	to	all)	of	admissions	had	been	
assessed	by	a	CRHT	team	and	that	20%	of	
admissions	could	have	been	suitable	for	CRHT	
instead.	Economic	analysis	for	the	NAO,	using	
a	decision	modelling	framework,	estimated	
a	saving	of	£69023	per	crisis	episode	with	full	
utilisation	of	a	CRHT	team	versus	when	no	such	
service	was	available.	This	economic	analysis	
concluded	that	at	least	£13.7	million	could	be	
saved	each	year	if	teams	in	which	a	below-
average	proportion	of	cases	involved	CRHT	
involvement	could	increase	involvement	to	the	
average	rate	of	53%.	They	estimated	potential	
savings	of	£59	million	a	year	if	the	involvement	
rate	was	90%	for	all	teams.	
Likewise	a	report	by	the	Healthcare	
Commission	(2008)	suggested	that	CRHT	
teams	were	not	as	fully	utilised	as	intended.	
During	a	six-month	study	period,	CRHTs	
were	involved	in	only	61%	of	almost	40,000	
admissions	to	acute	wards,	with	very	
substantial	variations	across	the	country	
(rates	ranged	from	9%	to	100%).	Likewise,	
only	25%	of	almost	40,000	discharges	from	
acute	wards	occurred	early	with	CRHT	support	
(rates	ranged	from	0%	to	70%).	This	evidence	
suggests	that	the	reduced	inpatient	bed	use	
following	the	introduction	of	CRHT	teams	is	not	
as	great	as	it	could	be,	which	in	turn	suggests	
that	further	cost	savings	could	be	made	if	fuller	
use	was	made	of	CRHT	teams.	
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PEER-SUPPORT WORKERS 
Soloman	(2004)	defines	peer	support	as	‘social	
emotional	support,	frequently	coupled	with	
instrumental	support,	that	is	mutually	offered	
or	provided	by	persons	having	a	mental	health	
condition	to	others	sharing	a	similar	mental	
health	condition	to	bring	about	a	desired	
social	or	personal	change.’	Such	support	
may	be	delivered	voluntarily	or	be	financially	
remunerated.	It	can	take	different	forms:	
self-help	groups,	internet	support	groups,	
peer-delivered	services,	peer-run	or	operated	
services	and	peer	employees	(Solomon	2004).	
Generally	an	important	distinction	is	that	these	
services	are	unlike	mutual	support	because	
peer-support	workers	receive	training	and	
supervision	(Repper	2011).	Whilst	some	of	these	
services	like	self-help	groups	have	long	formed	
a	part,	albeit	often	an	informal	part,	of	recovery	
from	mental	illness	in	the	National	Health	
Service,	others	are	relatively	new	and	have	yet	
to	become	mainstream	components	of	care.	
Peer-support	workers	are,	at	the	simplest	level,	
people	who	have	experienced	living	with	a	
diagnosis	of	severe	mental	illness	and	have	
been	able	to	recover.	Recovery	emerged	as	
a	psychiatric	concept	in	the	English-speaking	
world	in	the	1970s	and	has	largely	overtaken	
the	previous	traditional	medical	model	in	the	
US	(Davidson	2005).	It	defines	the	health	
outcome	as	overall	wellbeing	beyond	symptom	
management.	Of	central	importance	in	the	
‘recovery’	approach	is	the	very	different	
expectation	that	patients	can	lead	normal	
lives,	secure	employment,	further	education	
and	training,	and	independent	housing.	Peer-
support	workers	are	those	that	are	‘further	
along	their	road	to	recovery‘	(Deegan	1996;	
Repper	&	Carter	2011;	Davidson	et	al.	2006).	
Peer-support	workers	are	thought	to	benefit	
patients	by	sharing	their	experience,	provide	
an	empathetic	and	reciprocal	relationship,	
and	are	better	able	to	provide	hope	and	
encouragement,	which	in	combination	provide	
patients	with	empowerment,	confidence,	
and	increased	self-esteem	that	facilitates	the	
recovery	process	(Klein	et	al.	1998;	Forchuk	
et	al.	2005;	Davidson	et	al.	2006;	Lawn	2007;	
Rivera	et	al.	2007;	Repper	&	Carter	2011).
The	evidence	base	on	peer-support	workers	
largely	comes	from	the	US	and	as	recently	as	
2003	it	became	a	federally	reimbursed	service	
(The	President’s	New	Freedom	Commission	on	
Mental	Health	2003).	In	a	forthcoming	report	
from	the	Centre	for	Mental	Health,	it	was	found	
that	peer-support	workers	are	a	cost-effective	
component	of	service	delivery.	
The	evidence	base	on	peer-support	workers	
staffed	in	adjunct	positions	is	growing	and	
fairly	extensive,	although	is	also	heterogeneous	
with	respect	to	the	functions	and	service	
models	in	which	they	are	employed.	In	the	
forthcoming	report	from	the	Centre	for	Mental	
Health,	the	authors	identified	seven	studies	of	
good	design,	a	majority	of	which	were	either	
randomized	or	observational	studies,	with	
one	study	relying	on	expert	opinion	for	the	
estimation	of	hospital	days	saved.	Generally	
it	was	found	that	one	peer-support	worker	
could	save	a	significant	number	of	hospital	
days	per	individual	per	year	and	the	evidence	
base	seems	very	positive	in	this	regard.	The	
estimates	used	by	the	Centre	for	Mental	Health	
are	conservative,	reflecting	minimum	savings,	
although	the	studies	themselves	have	reported	
greater	reductions.	The	Centre	for	Mental	
Health,	using	UK	costs,	found	that	there	is	an	
almost	certain	likelihood	that	peer-support	
workers,	if	employed	and	paid	as	community	
support	workers,	would	generate	net	cost	
savings.	Across	the	eight	studies,	the	total	
sample	size	for	the	control	and	intervention	
groups	was	close	to	1,000	each	(Centre	for	
Mental	Health,	forthcoming).	In	these	included	
studies,	health	benefits	were	either	the	same	
as,	if	not	better	than	for	individuals	without	
peer	support.	
An	alternative	model	for	peer	support	is	when	
workers	are	employed	in	existing	case	manager	
roles.	Here,	three	studies	found	no	worsened	
outcomes	and	peer-support	workers	could	
function	in	the	same	way	as	case	managers	
with	no	experience	of	severe	mental	illness	
(Solomon	&	Draine	1995;	Clarke	et	al.	2000;	
Schmidt	et	al.	2008).	The	studies	found	no	
statistically	significant	difference	between	
individuals	in	relation	to	health	or	service	use	
outcomes	at	the	end	of	the	study.	While	it	
was	expected	that	patients	would	experience	
improved	outcomes,	at	least	in	service	use,	
24. Uprated to reflect current prices using the Pay and Prices Index reported in the PSSRU unit costs volume.
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Schmidt	(2008)	hypothesizes	this	may	be	
due	to	peer-support	workers	adopting	the	
professional	culture	to	fit	in	and	thus	downplay	
their	medical	history	and	rely	less	on	their	
personal	experience.	These	studies	were	
randomized	control	trials	with	sample	sizes	of	
less	than	50	in	each	group;	Clarke	et	al	(2000)	
replicated	the	same	study	design	as	Solomon	
and	Draine	(1995),	comparing	an	intervention	
team	fully	staffed	with	peer-support	workers	
as	case	managers	and	the	control	team	
staffed	with	case	managers	with	no	personal	
experience	of	a	sever	mental	illness	diagnosis.	
The	study	by	Schmidt	(2008)	may	be	limited	
in	its	ability	to	detect	differences	because	the	
intervention	was	staffed	by	only	one	peer-
support	worker	as	a	case	manager	in	a	team	
of	six	with	the	analysis	on	group	differences,	
limiting	the	ability	to	detect	any	differences	if	
there	were	any.
It	is,	however,	difficult	to	draw	firm	conclusions	
from	just	three	studies	focusing	on	the	cost-
effectiveness	in	terms	of	hospitalization,	and	
further	research	in	this	area	is	clearly	needed.
It	is	also	worth	noting	that	the	benefits	of	
employing	peer-support	workers	include	
not	just	benefits	relating	to	the	people	they	
support,	but	also	benefits	to	the	workers	
themselves	in	terms	of	being	in	gainful	
employment	and	all	the	associated	rewards	
that	this	brings.	
In	conclusion,	further	research	would	help	
to	generate	stronger	conclusions	about	
the	economic	implications	of	peer-support	
workers.	We	are	aware	of	a	number	of	ongoing	
projects	involving	peer	support	(Williams	
2011;	Mental	Health	Foundation	2012)	and	it	is	
hoped	that	these	will	contribute	helpfully	to	
the	evidence	base.	However,	the	most	recent	
work	by	the	Centre	for	Mental	Health	reaches	a	
similar	conclusion	to	previous	literature	reviews	
(	Davidson	et	al.	1999;	Simpson	&	House	2002;	
Doughty	&	Tse	2011;	Repper	&	Carter	2011;	
Wright-Berryman	et	al.	2011;	Davidson	et	al.	
2012)	that	the	results	are	promising	and	that	
there	are	health	benefits.	The	Centre’s	recent	
work,	however,	places	more	confidence	than	
previous	reviews	in	the	assertion	that	there	are	
significant	reductions	in	hospital	days,	given	
the	enhanced	evidence	base	now	available.
ADVANCED TREATMENT 
DIRECTIVES
Advanced	Treatment	Directives	are	documents	
drawn	up	to	express	a	patient	or	service	
user’s	preferences	concerning	treatment	
options	and	other	arrangements	in	the	event	
of	the	individual	losing	the	capacity	to	make	
that	decision	in	the	future.	The	preferences	
expressed	in	such	documents	can	be	
overridden	using	the	Mental	Health	Act,	but	the	
NICE	guidelines	(2009)	state	that	‘healthcare	
professionals	should	endeavour	to	honour	
advance	decisions	and	statements	wherever	
possible’.	Such	directives	have	strong	ethical	
appeal	as	they	give	people	with	schizophrenia	
a	right	to	self-determination	(including	the	
right	to	refuse	treatment)	at	times	when	they	
may	lack	capacity.	In	addition,	there	are	hopes	
that	such	directives	could	decrease	the	use	
of	coercion	and	involuntary	admission	during	
periods	of	relapse,	possibly	resulting	in	reduced	
service	use.
A	recent	Cochrane	systematic	review	of	
Advanced	Treatment	Directives	found	just	
two	published	studies	that	met	its	inclusion	
criteria	(most	studies	on	the	subject	were	
non-randomised	and	therefore	excluded).	The	
first	included	study	was	an	RCT	examining	the	
effects	of	making	a	low-intensity	Advanced	
Treatment	Directive	intervention	where	people	
with	schizophrenia	were	encouraged	to	fill	
in	a	booklet	containing	seven	preference	
statements	(e.g.	‘If	I	do	seem	to	be	becoming	
ill	again	I	would	like…’	and	‘If	I	have	to	be	
admitted	to	hospital	again	I	would	like…’).	
The	study	investigated	the	effects	of	the	
intervention	on	compulsory	re-admission	rates	
for	156	individuals	about	to	be	discharged	
from	two	psychiatric	inpatient	units	in	London	
(Papageorgiou	et	al.	2002).	The	study	found	
no	significant	differences	in	voluntary	or	
involuntary	readmission	in	the	one-year	follow-
up	period.	
The	second	study	was	a	single-blind	RCT	
measuring	the	effects	of	a	joint	crisis	plan	
that	was	‘formulated	by	the	patient,	care	
coordinator,	psychiatrist	and	the	project	worker	
and	contained	contact	information,	details	
of	mental	and	physical	illnesses,	treatments,	
indicators	for	relapse,	and	advance	statements	
of	preferences	for	care	in	the	event	of	future	
relapse’	(Henderson	et	al.	2004).	This	study	
was	also	carried	out	in	the	UK.	It	found	that	
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compulsory	admissions	were	significantly	
(p=0.028)	lower	for	the	intervention	group	
than	for	the	control	group,	with	a	risk	ratio	of	
0.48	(95%	CI:	0.25	to	0.95).	In	other	words,	
the	study	estimated	that	the	intervention	
reduced	compulsory	admissions	by	more	than	
one	half.	An	economic	evaluation	of	the	study	
estimated	that	the	service	costs	incurred	by	
the	intervention	group	were	£121024	lower,	
although	this	difference	was	not	statistically	
significant	(95%	CI:	-£3109	to	£5529).	The	
authors	concluded	that	there	was	a	greater	
than	78%	chance	that	the	Joint	Crisis	Plans	
are	more	cost-effective	than	standard	service	
information	(Flood	et	al.	2007).	
Jankovic	(2010)	suggested	the	observed	
differences	in	outcomes	between	these	
two	studies	could	be	due	to	the	fact	that	
Papageorgiuo	and	colleagues’	study	looked	
only	at	people	about	to	be	discharged	who	
had	been	undergoing	treatment	under	sections	
2,	3	or	4	of	the	Mental	Health	Act,	whereas	
Henderson	and	colleagues	looked	at	a	broader	
group	of	people	–	anyone	with	an	operational	
diagnosis	of	psychotic	illness	or	non-psychotic	
bipolar	disorder	who	had	experienced	hospital	
admission	within	the	previous	two	years.	
Additionally,	the	interventions	were	very	
different,	one	being	a	low-intensity	booklet	
not	supported	by	the	service	user’s	mental	
health	team,	whilst	the	other	intervention	fully	
involved	many	stakeholders.	
There	seems	to	be	some	positive	evidence	
that,	as	well	as	increasing	self-determination	of	
service	users,	Advance	Directives	may	result	
in	lower	service	use	and	service	costs.	More	
evidence	is,	however,	needed	before	a	firm	
conclusion	could	be	drawn	on	this	issue.	Two	
study	protocols	have	been	identified	describing	
RCTs	currently	in	progress	examining	the	
effects	of	Advanced	Directives	on	service	use	
and	costs	(Thornicroft	et	al.	2010;	Ruchlewska	
et	al.	2009).	These	studies	are	taking	place	
in	the	UK	and	the	Netherlands	respectively.	
The	results	and	analysis	of	these	studies	will	
hopefully	allow	more	conclusive	inferences	
to	be	made	on	the	economic	implications	of	
Advance	Directives.
COGNITIVE BEHAVIOUR 
THERAPY
Cognitive	Behaviour	Therapy	(CBT)	is	a	short-
term	talking	therapy	typically	comprising	of	
between	five	and	twenty	weekly	sessions	
with	homework	between	sessions.	As	its	
name	would	suggest,	CBT	focuses	on	thinking	
patterns	and	behaviour,	often	breaking	down	
problems	into	small	components	so	that	
straightforward	interventions	can	be	identified	
to	address	these	problems.	CBT	sessions	often	
comprise	of	discussions	with	the	therapist	
about	negative	beliefs	and	behavioural	
experiments	in	which	beliefs	are	tested	through	
25. This and other costs quoted in this paragraph were uprated to reflect current prices using the Pay and Prices Index 
in the PSSRU volume.
26. Uprated to reflect current prices.
Figure 7: Re-hospitalisation rates with CBT from Jones and colleagues (2012)
Rehospitalisation Pooled	sample	size Estimated	Risk	Ratio
95%	Confidence	
interval
Short	term 136 0.36 0.11	to	1.13
Medium	term 132 0.59 0.27	to	1.30
Long	term 294 0.86 0.61	to	1.20
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behavioural	changes.	The	elements	of	CBT	
that	are	different	from	other	psychological	
therapies	are	the	highly	structured	nature	of	
the	therapy,	the	focus	predominantly	on	the	
here-and-now	and	its	practical	nature.	CBT	has	
been	shown	to	be	beneficial	in	the	treatment	
of	a	wide	range	of	mental	health	conditions	
including	depression	and	anxiety	disorders.	
More	recently	it	has	been	recognised	that	
CBT	may	also	be	beneficial	for	individuals	
with	schizophrenia	by	helping	them	cope	with	
unhelpful	thoughts	and	behaviours.	CBT	is	
formally	recommended	by	NICE	yet	in	practice	
the	therapy	is	not	available	in	England	for	the	
majority	of	people	with	schizophrenia.
By	helping	people	with	schizophrenia	to	
address	negative	thoughts	and	behaviours,	
CBT	may	be	helpful	in	reducing	relapse	thus	
reducing	service	usage.	In	addition,	CBT	may	
equip	individuals	with	coping	mechanisms	
to	return	to	employment,	thus	providing	
additional	economic	benefits.	
Service Use
A	recent	Cochrane	systematic	review	(Jones	
et	al.	2012)	compared	CBT	with	other	
psychosocial	treatments	(both	‘active’	and	
‘non-active’	therapies).	A	meta-analysis	
of	relevant	studies	that	met	the	inclusion	
criteria	estimated	that	CBT	reduced	(but	not	
significantly)	readmission	rates	in	the	short,	
medium	and	long	run.	As	shown	in	Figure	7,	
the	estimated	effect	size	was	fairly	large,	but	
results	were	not	statistically	significant	due	to	
a	large	variance	and	relatively	small	pooled	
sample	size.	More	evidence	is	needed	before	
a	firmer	conclusion	could	be	drawn	as	to	how	
CBT	impacts	on	admission	rates	vis-à-vis	other	
psychological	therapies.
However,	since	many	people	with	schizophrenia	
do	not	have	access	to	any	kind	of	psychological	
therapy,	the	question	of	which	psychological	
therapy	may	be	seen	as	less	relevant.	For	
mental	health	services	who	do	not,	as	yet,	offer	
any	form	of	psychological	therapy,	a	more	
relevant	question	for	economic	evaluation	is	
what	are	the	costs	and	benefits	of	offering	
CBT	or	another	psychological	therapy	as	
compared	to	offering	no	such	service.	Another	
psychological	therapy	that	has	been	evaluated	
for	people	with	schizophrenia	is	cognitive	
remediation	therapy,	for	which	there	is	some	
encouraging	evidence	on	both	effectiveness	
and	cost-effectiveness	(Wykes	et	al.	2007,	
Patel	et	al.	2010).	An	earlier	study	evaluated	
what	was	called	‘compliance	(or	adherence)	
therapy’	for	people	who	were	leaving	an	
inpatient	setting	to	return	to	the	community	
(Healey	et	al.	1998).	It	found	cost-effectiveness	
advantages	for	the	intervention,	which	included	
motivational	interviewing,	but	a	subsequent	
multi-site	European	study	did	not	replicate	the	
findings	of	effectiveness	or	cost-effectiveness	
(Patel	et	al.	2012).
Simple	economic	modelling	by	NICE	involved	
a	meta-analysis	of	five	RCTs	(the	most	recent	
being	2003)	to	obtain	a	relative	risk	ratio	of	
hospitalisation	of	0.74	for	CBT	plus	standard	
care	compared	to	standard	care	alone	(95%	
CI:	0.61	to	0.94).	This	analysis	estimated	that	
a	full	course	of	CBT,	involving	16	individually	
delivered	sessions	with	a	clinical	psychologist,	
each	of	one	hour	in	duration,	cost	£1184.25	
However,	the	reduction	in	hospitalisation	
rates	implied	by	the	meta-analysis	led	NICE	
to	estimate	a	reduction	in	hospitalisation	cost	
of	£2277,	resulting	in	a	net	saving	due	to	CBT	
of	£989.	In	their	sensitivity	analysis,	varying	
rehospitalisation	rates	to	the	bounds	of	the	
95%	confidence	interval,	the	estimated	net	
cost	of	providing	CBT	ranged	between	-£1124	
(a	net	saving)	and	£829.	However,	more	recent	
controlled	trials	suggest	that	the	effectiveness	
of	CBT	on	reducing	relapse	and	hospitalisation	
rates	may	be	lower	than	that	assumed	used	
in	NICE’s	modelling.	The	RCTs	identified	by	
a	recent	review	(Lynch	et	al.	2010)	found	no	
significant	difference	in	relapse	rates	between	
CBT	and	control	groups	(Bechdolf	et	al.	2004;	
Tarrier	et	al.	2004;	Valmaggia	et	al.	2005;	
Barrowclough	et	al.	2006;	Garety	et	al.	2008),	
although	some	of	these	trials	were	testing	
group	CBT	which	may	affect	fidelity	and	
outcomes.	
Other	studies	have	attempted	to	analyse	the	
cost	implications	of	CBT	directly	by	recording	
service	use	and	calculating	associated	costs.	
Economic	outcomes	were	recorded	in	an	RCT	
of	CBT	for	acute	schizophrenia	in	North	Wales	
(Startup	et	al.	2005).	Positive	clinical	outcomes	
27. Converted into pounds sterling using PPP exchange rate as reported by OECD iLibrary. 
28. Converted into pounds sterling using PPP exchange rate as reported by OECD iLibrary. 
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were	reported,	with	the	CBT	group	scoring	
significantly	higher	than	the	control	group	on	
positive	symptoms,	negative	symptoms	and	
social	function	at	a	one-year	follow-up,	and	
significantly	higher	on	negative	symptoms	and	
social	functioning	at	the	two-year	follow-up.	
(They	also	appeared	to	score	higher	on	positive	
symptoms	at	the	two-year	follow-up,	but	the	
difference	was	not	statistically	significant.)	The	
economic	evaluation	of	the	trial	showed	that	
the	mean	cost	of	providing	CBT	was	£914,26	but	
this	cost	was	offset	by	a	reduction	in	service	
use.	Mean	total	costs	over	the	two-year	period	
were	slightly	lower	for	the	CBT	group	but	
the	difference	was	not	significant	(p=0.94).	
This	trial	provides	positive	evidence	for	the	
claim	that	CBT	is	a	cost-effective	treatment	
for	schizophrenia,	providing	superior	clinical	
outcomes	for	the	same	cost.	
A	more	recent	RCT	investigating	costs	
associated	with	CBT	in	the	Netherlands	(Van	
Der	Gaag	et	al.	2011)	found	that	CBT	was	
associated	with	better	clinical	outcomes	than	
treatment	as	usual	(183	days	of	normal	social	
functioning	vs.	106,	p<0.05)	but	higher	costs:	
the	CBT	group	had	mean	total	costs	of	£286027	
higher	than	the	comparison	group	over	an	
18-month	period,	although	this	difference	
was	not	significant.	The	authors	calculated	
a	cost	of	£3928	per	additional	day	of	normal	
functioning	gained,	which	suggested	that	CBT	
for	schizophrenia	could	be	a	cost-effective	
intervention	in	schizophrenia	if	society	is	willing	
to	pay	this	price.	
Employment
If	CBT	does	improve	outcomes	and	prevent	
relapse	in	schizophrenia,	this	may	lead	to	
increases	in	employment,	in	turn	leading	to	
additional	benefits,	both	to	the	Exchequer	
and	to	society.	However,	few	studies	could	
be	identified	that	included	employment	as	a	
measured	outcome.	Gumley	and	colleagues	
(2003)	found	employment	increased	2.1	times	
more	from	baseline	in	the	CBT	group	than	in	
the	treatment	as	normal	group	but	this	was	not	
significant	at	conventional	levels.	
Another	study	(Lysaker	et	al.	2005)	
investigated	the	use	of	‘enhanced	cognitive–
behavioural	therapy	for	vocational	
rehabilitation	in	schizophrenia.’	Fifty	
participants	were	offered	6-month	work	
placements,	and	were	randomised	to	receive	
either	standard	vocational	services	or	a	
programme	based	on	CBT	techniques	to	target	
beliefs	that	might	affect	vocational	functioning.	
Results	were	encouraging:	compared	to	
standard	vocational	services	group,	the	CBT	
group	worked	for	more	weeks	(p=0.02)	
and	more	hours	(p=0.06).	Caution	must	be	
exercised	in	applying	these	conclusions	to	
how	standard	CBT	might	affect	employment	
outcomes	since	this	CBT	programme	was	
designed	specifically	to	help	its	participants	
in	a	work	environment,	and	therefore	the	
effect	may	be	larger	than	for	more	typical	CBT	
courses.	However,	this	study	does	suggest	that	
there	may	be	additional	economic	benefits	to	
CBT	(in	addition	to	any	reduction	in	service	
use)	through	an	increase	in	paid	employment	
(and	thus	an	increase	in	tax	revenue	and	a	
reduction	in	benefits	dependence).
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In	this	report	we	have	described	both	the	main	costs	
associated	with	schizophrenia	and	the	economic	
implications	of	a	variety	of	interventions.	The	
interventions	considered	include	some	that	are	currently	
widely	used	in	practice,	as	well	as	some	that	have	yet	
to	be	fully	explored	or	applied	in	the	UK,	and	are	not,	
generally	speaking,	incorporated	into	mainstream	care,	
support	and	treatment	arrangements.	In	concluding	we	
offer	a	few	brief	comments.
CONCLUSIONS
First,	we	have	found	many	areas	where	both	
the	availability	and	quality	of	economic	
evidence	are	disappointing.	This	has	limited	
our	ability	to	say	very	much	about	the	likely	
economic	consequences	of	some	promising-
looking	interventions,	and	in	some	other	
cases	it	has	meant	that	we	can	only	set	out	
such	consequences	over	relatively	short	
time	periods.	Schizophrenia	is	an	illness	with	
potentially	lifelong	implications	for	individuals	
and	families,	and	it	would	be	helpful	if	the	
associated	economic	impacts	of	both	the	illness	
and	interventions	that	might	be	accessed	could	
be	more	reliably	projected.	
What	is	clear	from	the	evidence	that	we	
were	able	to	collate	in	this	report	is	that	
schizophrenia	has	very	significant	economic	
consequences	for	society.	Whilst	some	of	
the	costs	estimated	in	previous	studies	are	
unavoidable,	given	the	nature	of	schizophrenia	
–	because,	for	most	people,	the	illness	will	need	
treatment	of	some	kind	for	some	period	of	time	
–	there	is	nevertheless	strong	evidence	that	
several	interventions	that	are	not	currently	in	
widespread	use	could	reduce	the	overall	cost	of	
schizophrenia	while	improve	health	and	quality	
of	life	outcomes	for	people	with	the	illness	and	
for	their	families.
But	there	are	challenges	in	getting	the	right	
responses	to	this	evidence.	One	challenge	
is	obviously	the	general	economic	climate,	
particularly	in	view	of	the	austerity	measures	
being	implemented	across	public	and	non-
public	sectors	alike.	It	is	hardly	a	great	time	
to	be	proposing	additional	public	expenditure	
unless	savings	can	be	expected.	Moreover,	
those	savings	will	need	to	be	secured	in	
relatively	short	timescales,	whereas	some	of	the	
evidence	in	support	of	interventions	discussed	
in	this	report	suggests	that	the	economic	
advantages	might	take	a	number	of	many	years	
to	be	fully	realised.
A	linked	challenge	is	that	many	interventions	
require	expenditure	by	one	part	of	the	public	
sector	(and	often	this	will	be	the	NHS),	while	
many	of	the	payoffs	in	terms	of	savings,	
improved	productivity	and	so	on	could	well	
be	seen	in	other	parts	of	the	public	sector	or	
elsewhere.	One	consequence	and	challenge	
is	likely	to	be	a	need	for	negotiation	to	agree	
joint	courses	of	action	across	government	
departments,	local	council	budget	areas	or	
more	widely.	Without	such	coordination,	it	
could	hard	to	address	what	are	clearly	pressing	
issues	for	individuals,	families	and	communities.
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Some	interventions	will	not	produce	savings	
that	are	sufficient	to	cover	the	full	cost	of	the	
initial	investment	or	the	continued	support	of	
individuals	with	schizophrenia.	In	other	words,	
those	interventions	could	cost	more	than	
they	save.	This	is	absolutely	no	reason	for	not	
exploring	those	options	further,	because	the	
vast	majority	of	interventions	in,	for	example,	
the	health	field	or	the	criminal	justice	system	
also	do	not	generate	savings	that	exceed	
expenditures.	The	crucial	question	is	whether	
the	returns	to	those	expenditures	are	justified,	
and	that	means	making	comparisons	of	
costs	and	outcomes	between	interventions,	
not	just	for	people	with	schizophrenia	but	
for	people	with	other	health	needs,	and	
indeed	in	comparison	to	other	areas	of	public	
expenditure.
There	is,	finally,	also	the	question	of	
inequalities,	which	we	have	barely	touched	
on	in	this	report.	Because	of	the	devastating	
impact	of	an	illness	like	schizophrenia,	people	
with	the	condition	often	find	themselves	in	
personal	economic	difficulties.	Many	people	
with	schizophrenia	are	socially	isolated	or	in	
other	ways	socially	as	well	as	economically	
excluded.	Interventions	that	have	the	potential	
to	improve	their	quality	of	life	should	be	
considered	not	just	on	grounds	of	efficiency	
(i.e.	whether	the	health	or	quality	of	life	gains	
justify	the	costs),	but	also	on	the	grounds	of	
equity.	In	other	words,	do	those	interventions	
help	to	break	down	otherwise	entrenched	
positions	of	social	exclusion,	creating	better	life	
chances?
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